matchedPattern,context,lineNumber,columnNumber,publicationName
NM_001101.3,β-actin	NM_001101.3	CTTCCTTCCTGGGCATG	GTCTTTGCGGATGTCCAC	8...,32,9,3_Biotech_2016_Dec_13_6(1)_58.txt
NM_009170.3,...h	CAAGAAACTCCGAACGATTTAAGG	GCATTTAACTTGTCTTTGCACC	NM_009170.3	sonic hedgehog,61,53,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_010544.2,Ihh	GTGCATTGCTCTGTCAAGTCTG	GGTCTCCTGGCTTTACAGCTG	NM_010544.2	Indian hedgehog,62,50,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_007857.4,Dhh	TCCACGTATCGGTCAAAGCTGA	CCAGTCACCACGATGTAGTTCC	NM_007857.4	desert hedgehog,63,51,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_008957.2,...h1	CAGCTAATCTCGAGACCAACGTG	GAGTCTGTATCATGAGTTGAGG	NM_008957.2	patched homolog 1,64,54,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_176996.4,...mo	GACATGCACAGCTACATCGCAG	CGCAGGGTAGCGATTGGAGTTCC	NM_176996.4	smoothened homolog (Drosophila),65,52,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_008086.2,Gas1	TCAACGACTGCGTGTGCGATGG	GGACCGTTGCTCGCATCTGG	NM_008086.2	growth arrest specific 1,66,50,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_021339.2,...on	CCAGTGCGTTGCCAACAACAGC	TGGTACCCTGCAGCCAATGAAGC	NM_021339.2	cell adhesion molecule-related/down-re...,67,53,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_172506.2,...	TACACTGCTTTGGATTCTCATGG	AGTCACGTTCATCCATGGTGGCTC	NM_172506.2	biregional Cdon binding protein,69,54,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_010296.2,Gli1	ATAGTGAGCCATGCTGTCTCC	TCTCTCTGGCTGCTCCATAACC	NM_010296.2	GLI-Kruppel family member GLI1,70,51,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_001081125.1,...i2	TACCACCAGATGACCCTCATGG	CGTGGACTAGAGAATCGTGATGC	NM_001081125.1	GLI-Kruppel family member GLI2,71,53,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_008130.2,...i3	GAGAACAGATGTCAGCGAGAAGG	TGAGACCCTGCACACTCTGAGG	NM_008130.2	GLI-Kruppel family member GLI3,72,53,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_001025250.3,...a	CCTGGCTTTACTGCTGTACCTCC	AGCTTCGCTGGTAGACATCCATG	NM_001025250.3	vascular endothelial growth factor ...,73,55,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_011697.3,...gfb	AGCTGTGTGACTGTGCAGCGCTG	CATTGGCTGTGTTCTTCCAGG	NM_011697.3	vascular endothelial growth factor B,74,53,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_010228.3,Flt1	CCAGCATGTCATGCAAGCAGG	GTCAAGGTGCTGCAGAATTGC	NM_010228.3	FMS-like tyrosine kinase 1,75,50,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_010612.2,...r)	GGAGCCTACAAGTGCTCGTACC	GTTCTCGGTGATGTACACGATGC	NM_010612.2	kinase insert domain protein receptor,76,59,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_009640.4,...pt1	TCAGCATCTGGAGCATGTGATGG	TCAAGCATGGTGGCCGTGTGG	NM_009640.4	angiopoietin 1,77,54,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_007426.4,...2	TCTACCTCGCTGGTGAAGAGTCC	TGCAGATGCATTTGTCATTGTCC	NM_007426.4	angiopoietin 2,78,56,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_011587.2,...e1	GTGTCTGTCATGACCATGATGG	AGACCTCTACAACCTGCTGTGCC	NM_011587.2	tyrosine kinase with immunoglobulin-li...,79,53,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_013690.3,...k)	GAGGAAACCTGTTCACCTCAGC	ATGGCAGACTCCATTGTTCTTGC	NM_013690.3	endothelial-specific receptor tyrosine...,80,59,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_001131020.1,...TGGAGAGGGACAACTTTGCACAGG	CTTCATCTGCCTCCTGTCTATACG	NM_001131020.1	glial fibrillary acidic protein,81,56,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_009911.3,...4	ATGGAACCGATCAGTGTGAGTATA	AGATGATGAAGTAGATGGTGGG	NM_009911.3	chemokine (C-X-C motif) receptor 4,82,55,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_010431.2,"...1a	AAGCTTCTGTTATGAGGCTCACC	CACCATCACAAAGCCATCTAGG	NM_010431.2	hypoxia inducible factor 1, alpha subu...",83,54,Acta_Histochem_Cytochem_2016_Apr_28_49(2)_67-74.txt
NM_001164508.1,"...g sequence of the nebulin cDNA reference sequence NM_001164508.1, and its translation",25,690,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
NM_058246.3,...Phe100Val change in the chromosome 7 DNAJB6 gene (NM_058246.3) was noted (Fig. 5). Sanger sequencing...,113,298,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
NM_004104.4,"...mRNA (NM_000698, 315 to 335) and human FASN mRNA (NM_004104.4, 1210 to 1231) and control siRNA were ...",38,243,Acta_Pharmacol_Sin_2011_Jul_6_32(7)_921-929.txt
NM_012240.2,...mer for SIRT4 [35] were derived from the sequence NM_012240.2 (5´-GCACACTGGGCTTTGAGC-3´ and 5´-CACAA...,115,54,Aging_(Albany_NY)_2016_Feb_26_8(3)_484-505.txt
NM_005135.2,...Nucleotide enumeration was based on Genbank entry NM_005135.2. All constructs were confirmed by DNA ...,37,582,Am_J_Hematol_2014_Mar_14_89(3)_273-281.txt
NM_001001150.2,"...esigned based on the Bos taurus genome reference, NM_001001150.2 (UCSC Genome Browser assembly ID: O...",65,345,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_001001150.2,... based on the cattle (Bos taurus) genome assembly NM_001001150.2 (UCSC Genome Browser assembly ID: O...,68,583,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_001001150.2,"...l stop (p.Arg110*) at position chr22: 32 322 242 (NM_001001150.2) in MITF exon 3 (Fig. 2), whereas t...",80,748,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_001001150.2,...Glu281_Leu282Ins8) at position chr22: 32 297 683 (NM_001001150.2) in intron 8 (Fig. 3),80,922,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_001001150.2,...ence in solid buffaloes. (b) A nonsense mutation (NM_001001150.2) causing a premature translational ...,82,210,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_001001150.2,"...olid buffaloes. (b) A donor splice‐site mutation (NM_001001150.2) c.840+2T>A, p.Glu281_Leu282Ins8 at...",84,258,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_001001150.2,...according to the cattle reference genome assembly NM_001001150.2 (UCSC Genome Browser assembly ID: O...,114,84,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
NM_000557.2,"...t (Applied Biosystems,) (Reference cDNA sequence: NM_000557.2). Sequence analysis of GDF5 revealed a...",17,415,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
NR_043905.1,...and a 97.5% identity match with GenBank sequences NR_043905.1 (M. senuense) and GQ184162.1 (M. terra...,18,580,Ann_Lab_Med_2013_Sep_8_33(5)_356-359.txt
NM_000218.2,"...ns 7-10, c.922-?_c.1393+?del, reference sequence: NM_000218.2) and a frameshift mutation (c.1893dup;...",21,153,Ann_Lab_Med_2014_Sep_21_34(5)_395-398.txt
NM_005157.4,"...as performed twice, and a missense mutation [ABL1 NM_005157.4: c.763G>A (p.Glu255Lys)] was newly det...",15,749,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
NM_005157.4,... arrow) of the ABL1 gene was changed from G to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,478,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
NM_014143.3,"...eting exon4 of human Cd274, transcript variant 1 (NM_014143.3), were designed and constructed by Cel...",29,761,Appl_Immunohistochem_Mol_Morphol_2015_Sep_18_23(8)_541-549.txt
NM_000603.4,cDNA for NOS3 (NM_000603.4) relative quantification was produce,142,16,Arq_Bras_Cardiol_2015_Mar_104(3)_195-200.txt
NM_003247.1,...ed to determine gene expression levels for TSP-2 (NM_003247.1),46,685,Arthritis_Res_Ther_2008_Aug_21_10(4)_R96.txt
NM_024302.1,...s of MMP28 (Affymetrix gene identification number NM_024302.1) and the MMP28 precursor (Affymetrix g...,29,679,Arthritis_Res_Ther_2009_Dec_9_11(6)_R184.txt
NM_181667.1,ADAMTS4 F	CCTGGCAACGAGGACTCAAC	58	NM_181667.1,113,35,Arthritis_Res_Ther_2011_Dec_29_13(6)_R215.txt
NM_174288.1,Link protein F	AAGCTGACCTACGACGAAGCG	58	NM_174288.1,119,41,Arthritis_Res_Ther_2011_Dec_29_13(6)_R215.txt
NM_173923.2,IL-6 F	CTGGGTTCAATCAGGCGAT	58	NM_173923.2,122,31,Arthritis_Res_Ther_2011_Dec_29_13(6)_R215.txt
NM_002133.2,NM_002133.2	ggcagagggtgatagaagagg	agctcctgcaactcct...,51,2,Arthritis_Res_Ther_2016_Mar_1_18_56.txt
NM_000576.2,NM_000576.2	aaagcttggtgatgtctggtc	ggacatggagaacacc...,54,2,Arthritis_Res_Ther_2016_Mar_1_18_56.txt
NM_174314.2,"...nce of the bovine FABP4 in GenBank (Accession no. NM_174314.2), and genotypes at 9 SNPs were prelimi...",31,233,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
NM_174314.2,...mer sequence for SNPs of FABP4 (Accession number: NM_174314.2) gene of BTA 14 in Korean cattl,96,81,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
NM_174314.2,...on of exonic variants in FABP4 (Accession number: NM_174314.2) in Korean cattl,132,88,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
NM_174314.2,...ts of exonic variants in FABP4 (Accession number: NM_174314.2) on fatty acid composition of intramus...,177,74,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
NM_205518.1,β-actin	F:GAGAAATTGTGCGTGACATCA	58	152	NM_205518.1,68,40,Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_310-315.txt
XM_422636.3,CRBP II	F: GGCTACATGGTTGCACTAGACA	58	163	XM_422636.3,70,42,Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_310-315.txt
NM_001129967.1,"...stigated. In previous study, there was a 1351T>C (NM_001129967.1) transition and a 1666A>C (NM_00112...",81,154,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
NM_001129967.1,...351T>C (NM_001129967.1) transition and a 1666A>C (NM_001129967.1) transversion found in the 3′ end o...,81,196,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
NM_213824.3,R : GCACAAACACGCACCTCAA	80	NM_213824.3,84,28,Asian-Australas_J_Anim_Sci_2016_Aug_18_29(8)_1095-1101.txt
XM_005665507.1,R : AAGCAATCTCATCGAAGGTCC	119	XM_005665507.1,86,31,Asian-Australas_J_Anim_Sci_2016_Aug_18_29(8)_1095-1101.txt
NM_001007191.1,R : TGGCCTCGTCTTCCGGGTCATAGT	121	NM_001007191.1,90,34,Asian-Australas_J_Anim_Sci_2016_Aug_18_29(8)_1095-1101.txt
NM_006201.4,...iques. The coding regions of PCTAIRE-1 isoform 1 (NM_006201.4) and 14-3-3ζ (NM_003406.3) were amplif...,30,127,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
NM_003406.3,...of PCTAIRE-1 isoform 1 (NM_006201.4) and 14-3-3ζ (NM_003406.3) were amplified from human placental R...,30,153,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
NM_145012.4,"...ere amplified from human placental RNA, cyclin Y (NM_145012.4) from testes RNA (Agilent Technologies...",30,217,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
NM_005228.3,aReference sequence identical to NM_005228.3 b Modified from [7],37,34,Biol_Proced_Online_2010_Nov_11_13_1.txt
NM_005228.3,"... (ENSEMBL sequence: ENST00000275493, identical to NM_005228.3) and for GAPDH, Ensembl sequence: ENSG...",66,1133,Biol_Proced_Online_2010_Nov_11_13_1.txt
NM_002046.3,"..., Ensembl sequence: ENSG00000111640, identical to NM_002046.3 ). The primers were designed using the...",66,1209,Biol_Proced_Online_2010_Nov_11_13_1.txt
NM_052807.2,NM_052807.2	5‘-TGG ACC CAG TAT GCA GTC TAT G-3,37,1,Biol_Sport_2016_Jun_6_33(2)_99-106.txt
NM_053826.2,NM_053826.2	5‘-CAG GGT GTG ACT GAA TAC AAG G-3,43,1,Biol_Sport_2016_Jun_6_33(2)_99-106.txt
NM_000059.1,"... MA USA). Reference sequence for BRCA2: Genebank, NM_000059.1. By this mean, we revealed a compound ...",84,487,Biomark_Res_2015_Jun_6_3_13.txt
NM_001082253.1,Rab. GAPDH F.P.	NM_001082253.1	ATGGCCTCCAAGGAGTAAGA	149,119,17,Biomed_Res_Int_2014_Mar_30_2014_121098.txt
XM_663205.1," Glutathione peroxidase 1	 	—	—	XM_663205.1	XM_626631.1	[58, 68, 126]",157,33,Biomed_Res_Int_2015_Jan_28_2015_351289.txt
XM_626631.1," Glutathione peroxidase 1	 	—	—	XM_663205.1	XM_626631.1	[58, 68, 126]",157,45,Biomed_Res_Int_2015_Jan_28_2015_351289.txt
NM_001014431.1,...re of the human AKT1 gene (gene accession number: NM_001014431.1) and the location of the seven SNPs...,89,77,Biomed_Res_Int_2015_Jun_7_2015_316829.txt
NM_014495.2,"...TRCN0000242782, Sigma Aldrich) targeting ANGPTL3 (NM_014495.2) or with non-target shRNA (SHCOO2, Sig...",22,207,Biosci_Rep_2014_Dec_12_34(6)_e00160.txt
NM_000064.2,...e coding exons and intron flanking regions of C3 (NM_000064.2) were amplified by the polymerase chai...,20,225,Blood_Res_2016_Sep_23_51(3)_210-213.txt
NM_011341.3,...ime PCR primers (Figure 4) to the RefSeq sequence NM_011341.3 [GenBank:46195814],146,162,BMC_Bioinformatics_2005_Jul_13_6_175.txt
XM_650121.1,...cture alignment from the E. histolytica sequence (XM_650121.1) using E. coli glycerol kinase (PDB IB...,83,1000,BMC_Bioinformatics_2010_Mar_24_11_151.txt
XM_650121.1,...enerate a second structure for E. histolytica GK (XM_650121.1) with the E. coli crystal structure (P...,106,512,BMC_Bioinformatics_2010_Mar_24_11_151.txt
NR_003285.1,...pport a false positive structure from 5.8 s rRNA (NR_003285.1.1). Comparable rRNA derived structures...,58,562,BMC_Bioinformatics_2016_Jan_13_17_31.txt
NM_001002289.1,"... cDNA, the putative rat mRNA sequence of 1728 pb (NM_001002289.1) provided by the NCBI genome annota...",126,81,BMC_Biotechnol_2011_Jan_5_11_1.txt
NM_001002289.1,"...) compared to the putative rat fut8 ORF sequence (NM_001002289.1), which were also found, at least f...",130,193,BMC_Biotechnol_2011_Jan_5_11_1.txt
NM_001002289.1,...fut8 cDNA when compared to the putative sequence (NM_001002289.1). Two of these SNP were also found ...,198,131,BMC_Biotechnol_2011_Jan_5_11_1.txt
NM_000515.3,"...uman growth hormone (hGH) without signal peptide (NM_000515.3; 573 bp), hGH 2 variant isoform 3 prec...",19,253,BMC_Biotechnol_2013_Mar_11_13_21.txt
NM_022558.3,"...3 bp), hGH 2 variant isoform 3 precursor (hGH2V3, NM_022558.3; 738 bp), hGH receptor (hGHR; NM_00016...",19,318,BMC_Biotechnol_2013_Mar_11_13_21.txt
NM_000163.4,"...hGH2V3, NM_022558.3; 738 bp), hGH receptor (hGHR; NM_000163.4, 1920 bp), porcine GH binding protein ...",19,360,BMC_Biotechnol_2013_Mar_11_13_21.txt
NM_214254.2,"...3.4, 1920 bp), porcine GH binding protein (pGHBP, NM_214254.2, 570 bp) or hGH binding protein (hGHBP...",19,418,BMC_Biotechnol_2013_Mar_11_13_21.txt
NM_000163.4,"..._214254.2, 570 bp) or hGH binding protein (hGHBP, NM_000163.4, 714 bp), was inserted into either pET...",19,470,BMC_Biotechnol_2013_Mar_11_13_21.txt
NM_001257093.1,...llistatin	F: 5′-TGGACCGAGGAGGACGTGAA-3′	60	160 bp	NM_001257093.1,141,53,BMC_Biotechnol_2014_Oct_21_14_87.txt
NM_174116.1,Myf5	F: 5′-ACCAGCCCCACCTCAAGTTG-3′	60	150 bp	NM_174116.1,145,46,BMC_Biotechnol_2014_Oct_21_14_87.txt
NM_001040478.2,MyoD	F: 5′-CGACTCGGACGCTTCCAGT-3′	60	181 bp	NM_001040478.2,147,45,BMC_Biotechnol_2014_Oct_21_14_87.txt
NM_001142509.1,CDK2	F: 5′-CATGGATGCCTCTGCACTCACTG-3′	60	102 bp	NM_001142509.1,153,49,BMC_Biotechnol_2014_Oct_21_14_87.txt
NM_001161857.1,Akt1	F: 5′-CAGCATCGTGTGGCAGGAC-3′	60	138 bp	NM_001161857.1,155,45,BMC_Biotechnol_2014_Oct_21_14_87.txt
NM_001111.3,"...to target the human ADAR1 mRNA (Genbank ACCESSION NM_001111.3 GI: 7669471) at position 206, which is...",30,132,BMC_Cancer_2006_Dec_8_6_282.txt
NM_001111.3,...ting transcripts of ADAR1 p150 (Genbank ACCESSION NM_001111.3 GI: 70166851) only. β-actin was also P...,36,570,BMC_Cancer_2006_Dec_8_6_282.txt
NM_002253.1,"... according to the GenBank sequence (Accession No. NM_002253.1): forward, 5'-AGCTCCCACCCTGCACTGA-3 an...",31,283,BMC_Cancer_2009_May_12_9_144.txt
NM_002253.1,"...f 20 specimens with that of GenBank Accession No. NM_002253.1, using the Blast 2 program http://www....",46,157,BMC_Cancer_2009_May_12_9_144.txt
NM_001001389.1,"...for detection of CD44; Hs00153304_m1 (CD44 total, NM_001001389.1, NM_001001390.1, NM_001001391.1, NM...",48,309,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001001390.1,"... CD44; Hs00153304_m1 (CD44 total, NM_001001389.1, NM_001001390.1, NM_001001391.1, NM_001001392.1, NM...",48,325,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001001391.1,"...4_m1 (CD44 total, NM_001001389.1, NM_001001390.1, NM_001001391.1, NM_001001392.1, NM_000610.3), Hs01...",48,341,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001001392.1,"..., NM_001001389.1, NM_001001390.1, NM_001001391.1, NM_001001392.1, NM_000610.3), Hs01081480_m1 (CD44v...",48,357,BMC_Cancer_2011_Sep_29_11_418.txt
NM_000610.3,"..., NM_001001390.1, NM_001001391.1, NM_001001392.1, NM_000610.3), Hs01081480_m1 (CD44v3-v10, NM_001001...",48,373,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001001389.1,"...01392.1, NM_000610.3), Hs01081480_m1 (CD44v3-v10, NM_001001389.1), Hs01081475_m1 (CD44v8-v10, NM_001...",48,414,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001001390.1,"...-v10, NM_001001389.1), Hs01081475_m1 (CD44v8-v10, NM_001001390.1), Hs01081473_m1 (CD44S, NM_00100139...",48,458,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001001391.1,"...D44v8-v10, NM_001001390.1), Hs01081473_m1 (CD44S, NM_001001391.1) and Hs01075866_m1 (CD44v2-v10, NM_...",48,497,BMC_Cancer_2011_Sep_29_11_418.txt
NM_000610.3,"...S, NM_001001391.1) and Hs01075866_m1 (CD44v2-v10, NM_000610.3). The RefSeqs; NM_001202555.1, NM_0012...",48,544,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001202555.1,"...075866_m1 (CD44v2-v10, NM_000610.3). The RefSeqs; NM_001202555.1, NM_001202556.1, NM_001202557.1 rec...",48,571,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001202556.1,"...2-v10, NM_000610.3). The RefSeqs; NM_001202555.1, NM_001202556.1, NM_001202557.1 recently added to t...",48,587,BMC_Cancer_2011_Sep_29_11_418.txt
NM_001202557.1,"....3). The RefSeqs; NM_001202555.1, NM_001202556.1, NM_001202557.1 recently added to the NCBI database...",48,603,BMC_Cancer_2011_Sep_29_11_418.txt
NM_008084.2,"... are based on mouse sequences (accession numbers: NM_008084.2 (gapdh), NM_010408.3 (hcn1), NM_008226...",59,86,BMC_Cell_Biol_2015_Jul_4_16_18.txt
NM_010408.3,"...equences (accession numbers: NM_008084.2 (gapdh), NM_010408.3 (hcn1), NM_008226.2 (hcn2), NM_008227....",59,107,BMC_Cell_Biol_2015_Jul_4_16_18.txt
NM_008226.2,"...numbers: NM_008084.2 (gapdh), NM_010408.3 (hcn1), NM_008226.2 (hcn2), NM_008227.1 (hcn3), and NM_001...",59,127,BMC_Cell_Biol_2015_Jul_4_16_18.txt
NM_008227.1,"... (gapdh), NM_010408.3 (hcn1), NM_008226.2 (hcn2), NM_008227.1 (hcn3), and NM_001081192.1 (hcn4)). Am...",59,147,BMC_Cell_Biol_2015_Jul_4_16_18.txt
NM_001081192.1,"...cn1), NM_008226.2 (hcn2), NM_008227.1 (hcn3), and NM_001081192.1 (hcn4)). Amplicon sizes of gapdh fr...",59,171,BMC_Cell_Biol_2015_Jul_4_16_18.txt
NM_001099952.2,"NM_001099952.2	Homo sapiens inositol 1,4,5-trispho...",114,1,BMC_Complement_Altern_Med_2016_May_21_16_136.txt
NM_000700.1,NM_000700.1	Homo sapiens annexin A1	ANXA1	9q21.13	...,115,1,BMC_Complement_Altern_Med_2016_May_21_16_136.txt
NM_006756.2,NM_006756.2	Homo sapiens transcription elongation ...,116,1,BMC_Complement_Altern_Med_2016_May_21_16_136.txt
NM_000574.3,"NM_000574.3	Homo sapiens CD55 molecule, decay acce...",117,1,BMC_Complement_Altern_Med_2016_May_21_16_136.txt
NM_206917.1,NM_206917.1	Homo sapiens nerve growth factor recep...,120,1,BMC_Complement_Altern_Med_2016_May_21_16_136.txt
XM_425994.2,"EVX1 even-skipped homeobox 1	XM_425994.2	NC1	D1,2	D1	D1",88,30,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001045842.2,DLX1 distal-less homeobox 1	NM_001045842.2	NC1	D1	NC1	D1,90,29,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_001233188.1,TLX3 T-cell leukemia homeobox 3	XM_001233188.1	U1	D1	ND	ND,92,33,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204614.1,CDX4 caudal type homeobox 4	NM_204614.1	U3	D3	D3	ND,94,29,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_419196.2,"SNAI2 snail homolog 2	XM_419196.2	U2,3	D2,3	D3	D3",96,23,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_418732.2,JAZF1 JAZF zinc finger 1	XM_418732.2	NC1	D1	NC1	D1,100,26,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001006192.1,XBP1 X-box binding protein 1	NM_001006192.1	U1	D1	D1	D1,102,30,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_419429.2,ATF3 activating transcription factor 3	XM_419429.2	U1	D1	D1	NC1,104,40,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204880.1,ATF4 activating transcription factor 4	NM_204880.1	U1	D1	D1	D1,106,40,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_427826.1,"...U domain, class 3, transcription factor 1 (Oct 6)	XM_427826.1	NC1,3	D1	D1	D1",108,60,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001031402.1,HDAC7A histone deacetylase 7A	NM_001031402.1	NC1	D1	NC1	D1,110,31,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_420178.2,HDAC8 histone deacetylase 8	XM_420178.2	NC1	D1	D1	D1,112,29,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_205327.1,"FGF3 fibroblast growth factor 3	NM_205327.1	U1,	D1	D1	NC1",114,33,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001031546.1,"FGF4 fibroblast growth factor 4	NM_001031546.1	U1,2,3	D1,2,3	NC1,3	D3",116,33,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001012767.1,"FGF8 fibroblast growth factor 8	NM_001012767.1	U1,3	NC1,2,3	NC/U1,3	NC1,3",118,33,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204714.1,FGF18 fibroblast growth factor 18	NM_204714.1	U1	D1	D1	NC1,120,35,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204800.1,"SPRY2 sprouty homolog 2	NM_204800.1	U1,3	D1,3	D1	D1",124,25,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_419341.2,"SPRED2 sprouty-related, EVH1 domain containing 2	XM_419341.2	U1	D1	D1	NC1",128,50,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204515.1,IL17RD interleukin 17 receptor D (SEF)	NM_204515.1	NC1	D1	D1	NC1,132,40,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_205531.1,"...less-type MMTV integration site family, member 8A	NM_205531.1	U1,2,3	D1,2,3	D1,2,3	D1,2,3",136,61,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001037269.1,"...less-type MMTV integration site family, member 5B	NM_001037269.1	U1,2,3	D1,2,3	D1,3	NC1,3",138,61,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204221.1,"FZD7 frizzled homolog 7	NM_204221.1	U1,3	D1	NC1	NC1",140,25,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204973.1,"DLL1 delta-like 1	NM_204973.1	U1,2,3	D1,2,,3	D1,3	NC1,3",146,19,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001030648.1,NET1 neuroepithelial cell transforming gene 1	NM_001030648.1	NC1	D1	D1	D1,150,47,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204823.1,"...R1 cerberus 1, cysteine knot superfamily, homolog	NM_204823.1	U1,3	D1	U1	D1",152,53,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204700.1,"CFC1 cripto, FRL-1, cryptic family 1	NM_204700.1	U1	D1	D1	NC1",154,38,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204360.1,"EPHA1 EPH receptor A1	NM_204360.1	U1,2,3	D1,2,3	D1,3	D1,3",156,23,BMC_Dev_Biol_2011_Mar_21_11_20.txt
XM_417001.2,"EDNRB endothelin receptor type B	XM_417001.2	U1	D1,2	D1	D1",158,34,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204120.1,"EDNRB2 endothelin receptor B subtype 2	NM_204120.1	U1,3	D1,3	D1	NC1",160,40,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204749.1,"...derived growth factor receptor, alpha polypeptide	NM_204749.1	U1,3	D1,3	D3	NC3",162,67,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_204509.1,...1 receptor tyrosine kinase-like orphan receptor 1	NM_204509.1	U1	D1	D1	D1,164,54,BMC_Dev_Biol_2011_Mar_21_11_20.txt
NM_001024586.1,...al study included the chicken TLR5 gene sequence (NM_001024586.1) in the analysis of TLR5 (see Table...,74,1077,BMC_Evol_Biol_2012_Jul_24_12_122.txt
NM_014251.2,...t. GenBank reference sequences were NT_079595 and NM_014251.2,41,211,BMC_Gastroenterol_2012_Oct_15_12_141.txt
NM_014251.2,...). GenBank reference sequences were NT_079595 and NM_014251.2 (AGC2 isoform 2). Sequencing was perfo...,126,230,BMC_Gastroenterol_2012_Oct_15_12_141.txt
NM_013109.1,...424700	4	3	85% (XM_049268)	Rattus norvegicus 96% (NM_013109.1)	355 (AAB27579.1)	97% (P32242)	Rattus ...,58,123,BMC_Genet_2002_Aug_13_3_14.txt
NM_181008.2,"...CSN2 and CSN1S2 was in amino acid 82 in CSN2 (Ref NM_181008.2), previously reported in NRC by Nilsen...",77,555,BMC_Genet_2011_Aug_11_12_70.txt
NM_181008.2,"...substitution (C>T) in amino acid 125 of CSN2 (Ref NM_181008.2), previously reported by Lien et al. [...",77,881,BMC_Genet_2011_Aug_11_12_70.txt
NM_181008.2,...iation site. * Translated protein position in Ref NM_181008.2 for CSN2 and Ref NM_ 174528.2 for CSN1...,88,377,BMC_Genet_2011_Aug_11_12_70.txt
NM_181001.2,... taurus TYR mRNA sequence deposited in GenBankTM (NM_181001.2). PrimerQuest® software (Integrated DN...,31,188,BMC_Genet_2012_Jul_20_13_62.txt
NM_000018.2,ACADVL	NM_000018.2	c.-63_-49dupGGGCGTGCAGGACGC	 	 	 	 	 	...,52,8,BMC_Genet_2013_Feb_19_14_6.txt
NM_000709.3,BCKDHA_1	NM_000709.3	c.118dupC	21692	29.5	NA	19	 	 	 	 	19....,56,10,BMC_Genet_2013_Feb_19_14_6.txt
NM_000709.3,BCKDHA_2	NM_000709.3	c.972C > T (p.F324)	15574	30.7	6	91	1....,58,10,BMC_Genet_2013_Feb_19_14_6.txt
NM_000071.2,CBS	NM_000071.2	c.959 T > C (p.V320A)	8715	24.4	7	91	0...,62,5,BMC_Genet_2013_Feb_19_14_6.txt
NM_000492.3,CFTR	NM_000492.3	c.1408 G > A (p.M470V)	9356	30.4	60	38...,64,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_004006.2,DMD	NM_004006.2	c.2645A > G (p.D882G)	2974	19.6	5	93	4...,67,5,BMC_Genet_2013_Feb_19_14_6.txt
NM_000152.3,GAA	NM_000152.3	c.324 T > C (p.C108)	7078	24.7	5	87	4....,72,5,BMC_Genet_2013_Feb_19_14_6.txt
NM_000153.2,GALC_1	NM_000153.2	c.328 + 19 T > A	107	0	66	34	33.64	0.0...,92,8,BMC_Genet_2013_Feb_19_14_6.txt
NM_000153.2,GALC_2	NM_000153.2	c.328 + 19 T > A	193	0	85	15	15.03	0.0...,104,8,BMC_Genet_2013_Feb_19_14_6.txt
NM_000155.2,GALT	NM_000155.2	c.776 G > A (p.R259Q)	27403	31.3	62	32...,113,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_001005741.2,GBA_1	NM_001005741.2	c.1225-34C > A	2621	22.8	2	96	96.26...,115,7,BMC_Genet_2013_Feb_19_14_6.txt
NM_001005741.2,GBA_2	NM_001005741.2	IVS8-34C > A	2827	22	3	96	96.11	2.5...,120,7,BMC_Genet_2013_Feb_19_14_6.txt
NM_004004.5,GJB2	NM_004004.5	c.35dupG	33377	20.8	NA	18	0.74	0.33	1....,123,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_000521.3,HEXB	NM_000521.3	c.185 T > C (p.L62S)	21320	33.2	8	86	3...,125,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_000203.3,IDUA	NM_000203.3	c.99 T > G / p.H33Q	34	10.2	6	91	2.94	...,132,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_015560.2,OPA1	NM_015560.2	c.93_96dupAAAA	179	0	NA	69	 	 	 	 	69....,145,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_004260.2,RECQL4	NM_004260.2	c.132A > G (p.E44)	5504	28.7	61	37	60....,148,8,BMC_Genet_2013_Feb_19_14_6.txt
NM_000199.3,SGSH	NM_000199.3	c.337_345delins11	7735	27.4	NA	23	 	 	...,160,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_000543.4,SMPD1	NM_000543.4	c.103CTGGCG[7]	5073	22.2	NA	88	 	 	 	 ...,166,7,BMC_Genet_2013_Feb_19_14_6.txt
NM_014795.3,ZEB2	NM_014795.3	c.2083C > T (p.R695X)	20800	24.9	75	24...,169,6,BMC_Genet_2013_Feb_19_14_6.txt
NM_178059.5,"...exon sequences obtained from GenBank/NCBI entries NM_178059.5 (Etl4-a), NM_029895.4 (Etl4-b), NM_001...",32,1442,BMC_Genet_2015_Dec_18_16_143.txt
NM_029895.4,"...d from GenBank/NCBI entries NM_178059.5 (Etl4-a), NM_029895.4 (Etl4-b), NM_001081006.1 (Etl4-c), NM_...",32,1464,BMC_Genet_2015_Dec_18_16_143.txt
NM_001081006.1,"...tries NM_178059.5 (Etl4-a), NM_029895.4 (Etl4-b), NM_001081006.1 (Etl4-c), NM_001177630.2 (Etl4-d), ...",32,1486,BMC_Genet_2015_Dec_18_16_143.txt
NM_001177630.2,"...), NM_029895.4 (Etl4-b), NM_001081006.1 (Etl4-c), NM_001177630.2 (Etl4-d), NM_001177631.1 (Etl4-e), ...",32,1511,BMC_Genet_2015_Dec_18_16_143.txt
NM_001177631.1,"...NM_001081006.1 (Etl4-c), NM_001177630.2 (Etl4-d), NM_001177631.1 (Etl4-e), BC158051.1, BC050016.1, B...",32,1536,BMC_Genet_2015_Dec_18_16_143.txt
XM_141525.1,"...CP1 predicted protein (AAK00713); LOC241768 mRNA (XM_141525.1), LOC244579 mRNA (XM_146430), SOX-4 pr...",96,508,BMC_Genomics_2003_Apr_2_4_13.txt
NM_006928.3,...xons and revealed a homology of 87% to the human (NM_006928.3) and 83% to mouse mRNA (NM_021882.4). ...,137,210,BMC_Genomics_2007_Sep_24_8_335.txt
NM_021882.4,"...to the human (NM_006928.3) and 83% to mouse mRNA (NM_021882.4). At protein level, the similarities w...",137,246,BMC_Genomics_2007_Sep_24_8_335.txt
NM_001034666.1,... kDa protein ATPase homologue 1 (AHSA1)	B. taurus/NM_001034666.1	TC243227	3 = 4 > 2 > 1,32,89,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001034666.1,... kDa protein ATPase homologue 1 (AHSA1)	B. taurus/NM_001034666.1	TC243227	3 = 4 > 2 > 1,33,89,BMC_Genomics_2008_Sep_17_9_421.txt
NM_004487.3,"...with transmembrane signal) 1, (GOLGB1)	H. sapiens/NM_004487.3	TC269106	1 > 2 = 3 = 4",34,118,BMC_Genomics_2008_Sep_17_9_421.txt
NM_022168.2,...duced with helicase C domain 1 (IFIH1)	H. sapiens/NM_022168.2	TC281891	3 > 4 > 2 > 1,35,79,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001035009.1,...myc downstream regulated gene 1 (NDRG1)	B. taurus/NM_001035009.1	TC257462	1 > 4,36,69,BMC_Genomics_2008_Sep_17_9_421.txt
NM_213911.1,... receptor membrane component 1 (PGRMC1)	S. scrofa/NM_213911.1	TC238451	4 = 3 > 2 > 1,40,78,BMC_Genomics_2008_Sep_17_9_421.txt
NM_213739.1,...ipoQ receptor family member VII (PAQR7)	S. scrofa/NM_213739.1	TC238374	3 > 4 > 2 = 1,41,82,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001003318.1,"...Ras, member oncogene family (RAB2A)	C. familiaris/NM_001003318.1	TC241036	4 = 3 > 2 > 1",42,66,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001034459.1,...667 (620)	Ribosomal protein L17 (RPL17)	B. taurus/NM_001034459.1	TC264931	4 > 3 > 2 > 1,43,56,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001003140.1,"... protein 1 (zona occludens 1, TJP1)	C. familiaris/NM_001003140.1	TC281469	2 = 3 > 1",45,80,BMC_Genomics_2008_Sep_17_9_421.txt
NM_139323.2,"...tion protein, beta polypeptide (YWHAB)	H. sapiens/NM_139323.2	TC251407	3 = 4 = 2 > 1",46,124,BMC_Genomics_2008_Sep_17_9_421.txt
NM_004906.3,...lms' tumour associating protein (WTAP)	H. sapiens/NM_004906.3	TC267553	4 = 3 > 2 > 1,47,68,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001207.4,...2)	Basic Transcription Factor 3 (BTF3)	H. sapiens/NM_001207.4	TC241093	4 = 2 > 3 > 1,49,63,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001034764.1,...106681 (396)	DNA Polymerase Beta (POLB)	B. taurus/NM_001034764.1	TC252856	4 = 1 > 3 > 2,50,53,BMC_Genomics_2008_Sep_17_9_421.txt
NM_002140.2,...us nuclear ribonucleoprotein K (HNRPK)	H. sapiens/NM_002140.2	TC260259	4 = 3 = 2 > 1,51,77,BMC_Genomics_2008_Sep_17_9_421.txt
NM_199190.1,"...nucleoprotein family, member 4 (LARP4)	H. sapiens/NM_199190.1	TC244218	3 > 2 > 1 > 4",52,73,BMC_Genomics_2008_Sep_17_9_421.txt
NM_174057.2,...lavin containing monooxygenase 3 (FMO3)	B. taurus/NM_174057.2	TC251612	1 > 2 = 3 = 4,54,67,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001083496.1,CF106665 (479)	Glyoxalase I (GLO1)	B. taurus/NM_001083496.1	TC254694	4 > 3 > 2 > 1,55,46,BMC_Genomics_2008_Sep_17_9_421.txt
NM_174433.2,CF106659 (349)	Peroxiredoxin (PRDX4)	B. taurus/NM_174433.2	TC239253	4 = 3 > 2 > 1,56,48,BMC_Genomics_2008_Sep_17_9_421.txt
NM_001872.3,...06687 (278)	Carboxypeptidase B2 (CPB2)	H. sapiens/NM_001872.3	TC240093	3 = 4 > 2 = 1,58,54,BMC_Genomics_2008_Sep_17_9_421.txt
NM_000133.2,...06639 (374)	Coagulation Factor IX (F9)	H. sapiens/NM_000133.2	TC286008	4 > 2 > 3 = 1,59,54,BMC_Genomics_2008_Sep_17_9_421.txt
NM_173919.2,...(269)	Histidine Rich Glycoprotein (HRG)	B. taurus/NM_173919.2	TC251128	3 > 4 > 2 = 1,60,60,BMC_Genomics_2008_Sep_17_9_421.txt
NM_213896.1,CF106650 (196)	N-Aminoacylase I (ACY-1)	S. scrofa/NM_213896.1	TC269425	4 = 3 = 2 > 1,62,51,BMC_Genomics_2008_Sep_17_9_421.txt
NM_174133.2,CF106684 (295)	Polyubiquitin (UBB)	B. taurus/NM_174133.2	TC260685	3 = 4 > 2 = 1,63,46,BMC_Genomics_2008_Sep_17_9_421.txt
NM_000210.2,...F106657 (384)	Integrin alpha-6 (ITGA6)	H. sapiens/NM_000210.2	TC285515	1 > 2 = 3 = 4,65,52,BMC_Genomics_2008_Sep_17_9_421.txt
NM_014241.3,...esponding protein isoform. The PTPLA gene [RefSeq:NM_014241.3] codes for the member A of the protein...,157,121,BMC_Genomics_2010_Dec_22_11(Suppl_5)_S4.txt
NM_003302.2,The TRIP6 gene [RefSeq:NM_003302.2] is a thyroid hormone receptor interac...,161,24,BMC_Genomics_2010_Dec_22_11(Suppl_5)_S4.txt
NM_003769.2,"...etail, the ASSETs corresponding to SFRS9 [RefSeq: NM_003769.2] and FLNA [RefSeq: NM_001456.3] genes ...",168,650,BMC_Genomics_2010_Dec_22_11(Suppl_5)_S4.txt
NM_001456.3,... to SFRS9 [RefSeq: NM_003769.2] and FLNA [RefSeq: NM_001456.3] genes were stably expressed between c...,168,681,BMC_Genomics_2010_Dec_22_11(Suppl_5)_S4.txt
NM_003302.2,...s (Table 6). The ASSET of the TRIP6 gene [RefSeq: NM_003302.2] was more expressed in the Hb4a than i...,168,1023,BMC_Genomics_2010_Dec_22_11(Suppl_5)_S4.txt
NM_001199909.1, NM_001199909.1,123,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004940680.1, XM_004940680.1,126,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001277411.1, NM_001277411.1,129,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001167752.2, NM_001167752.2,132,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004937471.1, XM_004937471.1,135,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004937841.1, XM_004937841.1,138,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_416332.4, XM_416332.4,142,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001005431.1, NM_001005431.1,146,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001030956.1, NM_001030956.1,149,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_416965.4, XM_416965.4,152,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004950318.1, XM_004950318.1,156,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_419014.3, XM_419014.3,159,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004938015.1, XM_004938015.1,162,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_417174.4, XM_417174.4,165,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_204672.1, NM_204672.1,168,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001007477.3, NM_001007477.3,171,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004944616.1, XM_004944616.1,174,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_419574.4, XM_419574.4,177,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001001766.1, NM_001001766.1,180,2,BMC_Genomics_2016_Aug_11_17_598.txt
XM_004946388.1, XM_004946388.1,183,2,BMC_Genomics_2016_Aug_11_17_598.txt
NM_001267057.1,...change at amino acid position 44 (mRNA accession: NM_001267057.1; protein accession: NP_001253986.1)...,90,1745,BMC_Genomics_2016_Jun_23_17(Suppl_2)_445.txt
NM_019507.2,"...ut for the detection of mRNA expression of T-bet (NM_019507.2), GATA-3 (NM_008091.3), ROR-c (NM_0112...",79,427,BMC_Immunol_2014_Feb_25_15_9.txt
NM_008091.3,"...f mRNA expression of T-bet (NM_019507.2), GATA-3 (NM_008091.3), ROR-c (NM_011281.2), Foxp3 (NM_00119...",79,449,BMC_Immunol_2014_Feb_25_15_9.txt
NM_011281.2,"...T-bet (NM_019507.2), GATA-3 (NM_008091.3), ROR-c (NM_011281.2), Foxp3 (NM_001199348.1), IFN-γ (NM_00...",79,470,BMC_Immunol_2014_Feb_25_15_9.txt
NM_001199348.1,"...GATA-3 (NM_008091.3), ROR-c (NM_011281.2), Foxp3 (NM_001199348.1), IFN-γ (NM_008337.3), IL-5 (NM_010...",79,491,BMC_Immunol_2014_Feb_25_15_9.txt
NM_008337.3,"...R-c (NM_011281.2), Foxp3 (NM_001199348.1), IFN-γ (NM_008337.3), IL-5 (NM_010558.1), IL-17 (NM_010552...",79,515,BMC_Immunol_2014_Feb_25_15_9.txt
NM_010558.1,"...oxp3 (NM_001199348.1), IFN-γ (NM_008337.3), IL-5 (NM_010558.1), IL-17 (NM_010552.3), IL-10 (NM_01054...",79,535,BMC_Immunol_2014_Feb_25_15_9.txt
NM_010552.3,"..., IFN-γ (NM_008337.3), IL-5 (NM_010558.1), IL-17 (NM_010552.3), IL-10 (NM_010548.2), TGF-β1 (NM_0115...",79,556,BMC_Immunol_2014_Feb_25_15_9.txt
NM_010548.2,"..., IL-5 (NM_010558.1), IL-17 (NM_010552.3), IL-10 (NM_010548.2), TGF-β1 (NM_011577.1), and TNF-α (NM_...",79,577,BMC_Immunol_2014_Feb_25_15_9.txt
NM_011577.1,"...IL-17 (NM_010552.3), IL-10 (NM_010548.2), TGF-β1 (NM_011577.1), and TNF-α (NM_013693.2). The reactio...",79,599,BMC_Immunol_2014_Feb_25_15_9.txt
NM_013693.2,"...0 (NM_010548.2), TGF-β1 (NM_011577.1), and TNF-α (NM_013693.2). The reaction was performed with an A...",79,624,BMC_Immunol_2014_Feb_25_15_9.txt
NM_008084.2,"... Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, NM_008084.2) was used as a housekeeping gene for n...",79,1017,BMC_Immunol_2014_Feb_25_15_9.txt
NM_021297.2,TLR4	NM_021297.2	F ctgggtgagaaatgagctggtaa	122	58 °C	96...,95,6,BMC_Immunol_2015_Jun_2_16_34.txt
NM_008689.2,NF-κB	NM_008689.2	F ccaaagaaggacacgacagaatc	127	58 °C	95...,99,7,BMC_Immunol_2015_Jun_2_16_34.txt
NM_010591.2,AP-1	NM_010591.2	F gccctggctgaactgcatag	180	58 °C	91.4	...,101,6,BMC_Immunol_2015_Jun_2_16_34.txt
NM_008084.2,GAPDH	NM_008084.2	F gacatcaagaaggtggtgaagc	117	58 °C	96....,103,7,BMC_Immunol_2015_Jun_2_16_34.txt
NM_007393.3,β-Actin	NM_007393.3	F agattactgctctggctcctagc	147	58 °C	93...,105,9,BMC_Immunol_2015_Jun_2_16_34.txt
NM_194248.1,...ng the sample sequences with reference sequences (NM_194248.1) from the GenBank database,31,1250,BMC_Med_Genet_2010_May_26_11_79.txt
NM_194248.1,...ed on GenBank reference sequence accession number NM_194248.1. The nucleotide 1 is its first nucleot...,46,84,BMC_Med_Genet_2010_May_26_11_79.txt
NM_004550.4,...S2	Mitochondrial complex 1 deficiency (252010)	AR	NM_004550.4 455_457delCTC	Ser152del	---	---	---	Pa...,86,58,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_024120.4,...F5	Mitochondrial complex 1 deficiency (252010)	AR	NM_024120.4 164A > G	Gln55Arg	---	---	---	Maternal...,88,59,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_139242.3, 3*	MTFMT	Leigh syndrome (256000)	AR	NM_139242.3 626G > A	Ser209Leu	201431517	0.1	CS117...,93,38,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_001953.3,...DNA depletion syndrome 1 (MNGIE type) (603041)	AR	NM_001953.3 1160G > A homozygote	Gly387Asp	---	---...,95,73,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_001014763.1, 5*	ETFB	Glutaric acidemia IIB (231680)	AR	NM_001014763.1 235G > A	Val79Ile	140608276	0.4	---...,99,44,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_153638.2,...ration with brain iron accumulation 1 (234200)	AR	NM_153638.2 137A > T	Asp46Val	148036492	0.2	---	Ma...,101,96,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_004563.2,"...	PCK2	PEPCK deficiency, mitochondrial (261650)	AR	NM_004563.2 731G > A	Arg244Gln	---	<0.02	---	Not i...",103,54,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_000531.5,...ine transcarbamylase deficiency (311250)	X-linked	NM_000531.5 298 + 5G > C hemizygote	---	72554348	0...,105,65,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_014946.3,9*/13	SPAST	Spastic paraplegia 4 (182601)	AD	NM_014946.3 1625A > G	Asp542Gly	142053576	<0.05	CM...,109,46,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_017882.2,...nosis (CLN) 6 (601780)/ CLN Kufs type (204300)	AR	NM_017882.2 278 T > C	Thr93Met	150001589	<0.04	CM1...,110,76,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_000339.2, 11	SLC12A3	Gitelman syndrome (263800)	AR	NM_000339.2 322C > T	Arg108Trp	---	---	CM117057	--...,112,43,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_000341.3, 12*	SLC3A1	Cystinuria (220100)	AR	NM_000341.3 241C > T	Arg81Cys	149813423	<0.02	CM09...,114,36,BMC_Med_Genet_2013_Nov_11_14_118.txt
NM_004429.4,...leotides were numbered according to GenBank entry NM_004429.4,88,612,BMC_Med_Genet_2016_Apr_30_17_35.txt
NM_006172.3,NM_006172.3	NPPA	1p36.22	2.2 (0.59) (shunt) 19.4 (...,101,1,BMC_Med_Genomics_2011_Jan_5_4_1.txt
NM_020975.4,"...tation position and sequence change. For example, NM_020975.4:c.2944C>T refers a C→T substitution ha...",40,281,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
NM_020975.4,...tution happened at position 2944 on cDNA sequence NM_020975.4; NP_009008.2:p.Arg42* indicates that A...,40,372,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
NM_000492.3,"... to users. For example (Figure 1.4), the mutation NM_000492.3:c.350G>A (id: M301052)in gene CFTR is ...",50,796,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
NM_000084.4,.... Transcripts including the untranslated exon 1a (NM_000084.4: mRNA variant 3) [2] or 1b (NM_0012821...,22,821,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001282163.1,... exon 1a (NM_000084.4: mRNA variant 3) [2] or 1b (NM_001282163.1: mRNA variant 4) [3] are spliced to...,22,861,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001127899.3,...ncluding exons I to IV have also been identified (NM_001127899.3: mRNA variant 1 and NM_001127898.3:...,22,1201,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001127898.3,...en identified (NM_001127899.3: mRNA variant 1 and NM_001127898.3: mRNA variant 2) [5]. Both of these...,22,1236,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001127899.3,.... The human CLCN5 mRNA (GeneBank accession number NM_001127899.3; NM_001127898.3; NM_000084.4; NM_00...,33,693,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001127898.3,...5 mRNA (GeneBank accession number NM_001127899.3; NM_001127898.3; NM_000084.4; NM_001282163.1 and NM...,33,709,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_000084.4,"... accession number NM_001127899.3; NM_001127898.3; NM_000084.4; NM_001282163.1 and NM_001272102.1), t...",33,725,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001282163.1,"...mber NM_001127899.3; NM_001127898.3; NM_000084.4; NM_001282163.1 and NM_001272102.1), the human CLCN...",33,738,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001272102.1,"...; NM_001127898.3; NM_000084.4; NM_001282163.1 and NM_001272102.1), the human CLCN5 DNA sequence on c...",33,757,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_000084.4,...+1 origin reported in the NCBI reference sequence NM_000084.4. This result is in agreement with in s...,60,609,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001282163.1,"...+1 origin reported in the NCBI reference sequence NM_001282163.1, but it was not possible to obtain ...",62,701,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001127899.3,"... which, according to the NCBI reference sequences NM_001127899.3 and NM_001127898.3, contain the tra...",66,187,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001127898.3,"...o the NCBI reference sequences NM_001127899.3 and NM_001127898.3, contain the transcriptional start ...",66,206,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_001272102.1,... we were not able to identify the mRNA variant 5 (NM_001272102.1). From these results we can conclud...,74,71,BMC_Med_Genomics_2014_Jul_7_7_41.txt
NM_012242.1,NM_012242.1	DKK1	0.1	0.5	0.9	1.6,117,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_002015.2,NM_002015.2	FOXO1A	-0.1	0.0	0.7	1.1,118,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005842.1,NM_005842.1	SPRY2	0.3	1.6	1.1	0.9,119,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_003243.1,NM_003243.1	TGFBR3	0.1	0.0	-0.3	0.7,121,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_030775.1,NM_030775.1	WNT5B	0.0	0.2	0.2	0.7,122,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_016932.1,NM_016932.1	SIX2	0.3	0.2	0.0	0.6,123,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001554.1,NM_001554.1	CYR61	0.4	0.4	0.1	0.5,125,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005359.1,NM_005359.1	MADH4	0.6	0.1	0.1	0.5,126,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_003062.1,NM_003062.1	SLIT3	0.2	0.0	0.0	0.5,132,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001430.1,NM_001430.1	EPAS1	0.2	0.1	0.0	0.5,133,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001423.1,NM_001423.1	EMP1	0.2	0.1	0.6	0.5,134,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_004335.2,NM_004335.2	BST2	0.2	0.1	0.4	0.4,135,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_003244.1,NM_003244.1	TGIF	0.3	0.1	0.4	0.4,136,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001448.1,NM_001448.1	GPC4	0.3	-0.1	0.2	0.4,140,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_000041.1,NM_000041.1	APOE	0.1	0.3	0.3	0.4,142,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_016453.1,NM_016453.1	AF3P21	0.2	0.2	0.2	0.4,143,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_006884.1,NM_006884.1	SHOX2	-0.1	0.0	-0.2	0.4,144,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_004472.1,NM_004472.1	FOXD1	0.2	0.4	0.0	0.3,145,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005251.1,NM_005251.1	FOXC2	-0.1	0.4	0.1	0.3,146,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_012062.1,NM_012062.1	DNM1L	0.4	0.0	0.0	0.3,147,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001992.2,NM_001992.2	F2R	0.1	-0.6	0.2	0.2,149,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_003483.2,NM_003483.2	HMGA2	0.0	0.0	0.6	0.2,150,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_013246.1,NM_013246.1	CLC	-0.1	0.4	-0.1	0.1,153,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005882.2,NM_005882.2	MAEA	0.4	0.0	-0.2	0.1,154,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_006350.2,NM_006350.2	FST	-0.2	-0.3	-0.7	-1.2,161,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005585.1,NM_005585.1	MADH6	0.2	-0.2	-0.4	-1.1,162,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001546.1,NM_001546.1	ID4	0.3	0.1	-0.6	-1.0,163,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005924.1,NM_005924.1	MEOX2	0.3	-0.2	0.0	-0.9,166,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_000346.1,NM_000346.1	SOX9	-0.1	0.0	-0.5	-0.8,167,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_018951.1,NM_018951.1	HOXA10	0.1	-0.3	-0.5	-0.7,171,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_002166.1,NM_002166.1	ID2	0.4	0.0	-0.4	-0.7,172,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_000600.1,NM_000600.1	IL6	0.2	0.0	-0.9	-0.6,173,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_002006.1,NM_002006.1	FGF2	0.1	-0.3	-0.6	-0.6,177,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_018951.1,NM_018951.1	HOXA10	0.0	-0.3	-0.3	-0.6,178,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_003633.1,NM_003633.1	ENC1	0.0	0.0	-0.1	-0.6,179,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001290.1,NM_001290.1	LDB2	0.1	0.1	-0.1	-0.4,181,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_002309.2,NM_002309.2	LIF	-0.1	0.2	-0.2	-0.4,182,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_002506.1,NM_002506.1	NGFB	-0.1	-0.1	-0.7	-0.4,183,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005095.1,NM_005095.1	ZNF262	0.0	0.1	0.3	-0.4,184,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_001356.2,NM_001356.2	DDX3	0.1	-0.1	-0.2	-0.4,185,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_020249.1,NM_020249.1	ADAMTS9	-0.4	-0.3	-0.1	-0.4,186,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_002167.1,NM_002167.1	ID3	0.2	0.0	-0.1	-0.4,192,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_004333.1,NM_004333.1	BRAF	-0.4	-0.4	-0.3	-0.4,193,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_005574.2,NM_005574.2	LMO2	0.0	-0.1	-0.4	-0.3,194,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_014240.1,NM_014240.1	LIMD1	-0.3	-0.2	-0.5	-0.3,197,1,BMC_Musculoskelet_Disord_2007_Feb_12_8_12.txt
NM_014140.3,Mutational analysis of SMARCAL1 gene [NM_014140.3 GI:187761312; NG_009771.1 GI:223671908...,26,39,BMC_Nephrol_2014_Mar_3_15_41.txt
NM_014140.3,...w.hgvs.org/mutnomen) and NCBI Reference Sequence [NM_014140.3 GI:187761312]. The potential effect of...,26,651,BMC_Nephrol_2014_Mar_3_15_41.txt
NM_014140.3,...rams showing detected mutations of SMARCAL1 gene [NM_014140.3 GI:187761312] in exons 3 and 17 of pro...,30,94,BMC_Nephrol_2014_Mar_3_15_41.txt
NM_010838.3,...) and an antisense primer located at 1281–1262 in NM_010838.3 were used for first strand synthesis. ...,75,802,BMC_Neurosci_2013_Nov_22_14_148.txt
NM_010838.3,...t 671–690 (in exon 9) and 975–954 (in exon 11) in NM_010838.3 as to simultaneously assay 3R-tau and ...,75,971,BMC_Neurosci_2013_Nov_22_14_148.txt
NM_001249223.1,"...reviously reported soybean GLYI protein (GenBank: NM_001249223.1). Subsequently, each of the newly i...",34,695,BMC_Plant_Biol_2016_Apr_16_16_87.txt
NM_001249223.1,... reported soybean GLYI protein sequence (GenBank: NM_001249223.1) and Brassica juncea GLYII protein ...,377,260,BMC_Plant_Biol_2016_Apr_16_16_87.txt
NM_006886.2,"...g to the mRNA sequences NM_00101071 for TYMS (and NM_006886.2, and NM_001001977.1 for ATP5E. qPCRs w...",37,309,BMC_Pulm_Med_2015_Oct_26_15_132.txt
NM_001001977.1,"...uences NM_00101071 for TYMS (and NM_006886.2, and NM_001001977.1 for ATP5E. qPCRs were performed usi...",37,326,BMC_Pulm_Med_2015_Oct_26_15_132.txt
NM_001071.2,"... expression analysis. NCBI Reference Sequence was NM_001071.2 (Homo sapiens thymidilate synthetase, ...",39,450,BMC_Pulm_Med_2015_Oct_26_15_132.txt
NM_006886.3,"...ATP5E reference gene. NCBI Reference Sequence was NM_006886.3 (Homo sapiens ATP synthase, H+ transpo...",39,1132,BMC_Pulm_Med_2015_Oct_26_15_132.txt
NM_019888.3,"...5′UTR) from position −1 to −984 of the MC3R gene (NM_019888.3) were synthesized (MWG Eurofins, Ebers...",19,579,BMC_Res_Notes_2013_Mar_15_6_99.txt
NM_000492.3,...e regulator (CFTR) gene [NCBI Reference Sequence: NM_000492.3] [1]. There are more than 1900 mutatio...,17,221,BMC_Res_Notes_2013_Nov_13_6_461.txt
NM_078724.6,... for Biotechnology Information database: DmGr21a (NM_078724.6) and DmGr63a (NM_001144411.1) from D. ...,30,143,BMC_Res_Notes_2016_Jan_8_9_18.txt
NM_001144411.1,"...tion database: DmGr21a (NM_078724.6) and DmGr63a (NM_001144411.1) from D. melanogaster, GPRGR24 (DQ9...",30,169,BMC_Res_Notes_2016_Jan_8_9_18.txt
XM_312786.3,"... (DQ989013.1), GPRGR22 (DQ989011.1), and GPRGR23 (XM_312786.3) from Anopheles gambiae, and TcGr1 (AM...",30,264,BMC_Res_Notes_2016_Jan_8_9_18.txt
XM_008193301.1,"...Anopheles gambiae, and TcGr1 (AM292331.2), TcGr2 (XM_008193301.1), and TcGr3 (XM_001814609.2) from T...",30,332,BMC_Res_Notes_2016_Jan_8_9_18.txt
XM_001814609.2,"... (AM292331.2), TcGr2 (XM_008193301.1), and TcGr3 (XM_001814609.2) from T. castaneum. These protein s...",30,360,BMC_Res_Notes_2016_Jan_8_9_18.txt
XM_535300.2,MMP-2	[GenBank:XM_535300.2]	F: gggaccacggaagactatg,41,16,BMC_Vet_Res_2011_Jul_4_7_33.txt
NM_001003219.1,MMP-9	[GenBank:NM_001003219.1]	F: tgagaactaatctcactgacaagc,44,16,BMC_Vet_Res_2011_Jul_4_7_33.txt
XM_536598.2,MMP-13	[GenBank:XM_536598.2]	F: ctcttcttctcgggaaacc,47,17,BMC_Vet_Res_2011_Jul_4_7_33.txt
XM_843664.1,MT1-MMP	[GenBank:XM_843664.1]	F: gatctgaatgggaatgacatct,50,18,BMC_Vet_Res_2011_Jul_4_7_33.txt
NM_001003182.1,TIMP-1	[GenBank:NM_001003182.1]	F: cagggcctgtacctgtg,53,17,BMC_Vet_Res_2011_Jul_4_7_33.txt
NM_001003082.1,TIMP-2	[GenBank:NM_001003082.1]	F: atgagatcaagcagataaagatgtt,56,17,BMC_Vet_Res_2011_Jul_4_7_33.txt
XM_538410.2,TIMP-3	[GenBank:XM_538410.2]	F: tgctgacaggccgcg,59,17,BMC_Vet_Res_2011_Jul_4_7_33.txt
NM_001002985.1,RECK	[GenBank:NM_001002985.1]	F: aaggggtgtctgtctggaga,62,15,BMC_Vet_Res_2011_Jul_4_7_33.txt
XM_531662.2,CGI-119	[GenBank:XM_531662.2]	F: tctacaatctaagagagatttcagca,65,18,BMC_Vet_Res_2011_Jul_4_7_33.txt
XM_537849.2,GOLGA-1	[GenBank:XM_537849.2]	F: ggtggctcaggaagttcag,68,18,BMC_Vet_Res_2011_Jul_4_7_33.txt
NM_001098598.1,RPP0	CAACCCTGAAGTGCTTGACA	204	NM_001098598.1,294,31,BMC_Vet_Res_2014_Sep_9_10_210.txt
NM_214022.1,TNFα	AACCCTCTGGCCCAAGGA	57	NM_214022.1,296,28,BMC_Vet_Res_2014_Sep_9_10_210.txt
NM_001005149.1,IL-1β	AAAGGGGACTTGAAGAGAG	286	NM_001005149.1,298,31,BMC_Vet_Res_2014_Sep_9_10_210.txt
NM_214041.1,IL-10	GCATCCACTTCCCAACCA	446	NM_214041.1,300,30,BMC_Vet_Res_2014_Sep_9_10_210.txt
XM_545752.4,...APN1:c.344G > A and KCNJ10:c.627C > G (Transcript XM_545752.4) mutations in a sample of 77 PRT and 9...,8,276,BMC_Vet_Res_2016_Oct_10_12_225.txt
XM_545752.4,"...channel, subfamily J, member 10) gene (Transcript XM_545752.4) was found to be strongly associated w...",26,161,BMC_Vet_Res_2016_Oct_10_12_225.txt
XM_005640901.1,...el we used for KCNJ10 was based on the transcript XM_005640901.1 of the dog genome assembly CanFam3....,43,63,BMC_Vet_Res_2016_Oct_10_12_225.txt
XM_545752.4,...ds (aa). A previous study [7] used the transcript XM_545752.4 as gene model (denoted XM_545752.3 in ...,43,309,BMC_Vet_Res_2016_Oct_10_12_225.txt
XM_545752.3,"...the transcript XM_545752.4 as gene model (denoted XM_545752.3 in previous reports [7, 11]) with two ...",43,344,BMC_Vet_Res_2016_Oct_10_12_225.txt
XM_005640901.1,...n (assembly CanFam3.1). (A) represents transcript XM_005640901.1 and (B) represents XM_545752.4. Tra...,130,174,BMC_Vet_Res_2016_Oct_10_12_225.txt
XM_545752.4,...ents transcript XM_005640901.1 and (B) represents XM_545752.4. Translated exons are shown as black b...,130,208,BMC_Vet_Res_2016_Oct_10_12_225.txt
NM_003072.1,...xons and the flanking intronic sequences of BRG1 (NM_003072.1) were amplified in 38 fragments. Denat...,18,66,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
NM_016289.2,"...Dα (BK001542.1), the eight coding exons of MO25α (NM_016289.2), and the flanking intronic regions wa...",20,104,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
NM_000051.3,The ATM cDNA (mRNA RefSeq NM_000051.3) representing the complete open readin...,36,27,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
NM_000051.3,...se mutation located in the first base of exon 60 (NM_000051.3) in the kinase domain. It was expected...,58,519,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
NM_016834.4,...rised pMT vector. The ORF for MAP (Gene ID: 4137; NM_016834.4) was modified with 5′-NotI and 3′-BlpI...,33,215,Br_J_Cancer_2013_Sep_17_109(6)_1570-1578.txt
NM_008493.3,NM_008493.3	AGGATGACACCAAAACCCTCAT	AGTCCAAGCCAGTGA...,313,2,Br_J_Nutr_2016_Jun_14_115(11)_1930-1937.txt
NM_008590.1,NM_008590.1	TCAGTGACAAGCCGAGACCA	GTTGATTCTGCGGTTCT...,316,2,Br_J_Nutr_2016_Jun_14_115(11)_1930-1937.txt
NM_010052.5,NM_010052.5	TGCGAGGCTGACAATGTCTG	ATGCACTGCCATGGTTC...,319,2,Br_J_Nutr_2016_Jun_14_115(11)_1930-1937.txt
NM_007597.3,NM_007597.3	AGAGCTCAGCCTGGATCAATTC	TTGTAGTCCTCTCCA...,323,2,Br_J_Nutr_2016_Jun_14_115(11)_1930-1937.txt
NM_009078.2,NM_009078.2	TTGCCTCTAGTGTCCTCCGC	CTTCCTGATCTGCTGAC...,326,2,Br_J_Nutr_2016_Jun_14_115(11)_1930-1937.txt
NM_009093.2,NM_009093.2	AGTCACCCACGGAAGTTCGG	GTCCAACTTAATGAAGC...,329,2,Br_J_Nutr_2016_Jun_14_115(11)_1930-1937.txt
NM_001101426.3,...ide numbering based on GenBank reference sequence NM_001101426.3. Nucleotide numbering denotes the a...,108,150,Brain_2013_Jan_3_136(1)_269-281.txt
NM_001101426.3,"...tations are named according to reference sequence NM_001101426.3 (Fig. 5), corresponding to the long...",116,64,Brain_2013_Jan_3_136(1)_269-281.txt
NM_001101417.3,...soform is not present in the other short isoform (NM_001101417.3). Exome sequencing in Case 4 showed...,116,223,Brain_2013_Jan_3_136(1)_269-281.txt
NM_031512.2,"...rse: 5′-TCCCGACCATTGCTGTTTCC-3′ (519 bp, GeneBank NM_031512.2). Primers used for TNF-α were: forward...",40,971,Braz_J_Med_Biol_Res_2012_Jun_22_45(10)_968-976.txt
NM_012675.3,"...rse: 5′-GCTACGGGCTTGTCACTCGA-3′ (145 bp, GeneBank NM_012675.3). Primers used for β-actin mRNA were: ...",40,1108,Braz_J_Med_Biol_Res_2012_Jun_22_45(10)_968-976.txt
NM_031144.2,"...rse: 5′-CGACGACGAGCGCAGCGATA-3′ (100 bp, GeneBank NM_031144.2). The amplification conditions consist...",40,1253,Braz_J_Med_Biol_Res_2012_Jun_22_45(10)_968-976.txt
NM_008289.2,"... In brief, the m11βHSD2 (NCBI reference sequence: NM_008289.2)19 sequence and the crystal structure ...",14,165,Cancer_Inform_2011_Dec_1_10_287-295.txt
NM_001993.2,"...e involved in thrombosis (F3 (tF): ref. sequence: NM_001993.2, assay ID: Hs00175225_m1, amplicon len...",106,264,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_004233.3,"...con length: 118), apoptosis (CD83: ref. sequence: NM_004233.3, assay ID: Hs00188486_m1, amplicon len...",106,357,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_004530.2,"...86_m1, amplicon length: 104, MMP2: ref. sequence: NM_004530.2, assay ID: Hs00234422_m1, amplicon len...",106,438,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_004994.2,"...422_m1, amplicon length: 83, MMP9: ref. sequence: NM_004994.2, assay ID: Hs00234579_m1, amplicon len...",106,518,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_003254.2,"...79_m1, amplicon length: 54, TIMP1: ref. sequence: NM_003254.2, assay ID: Hs99999139_m1, amplicon len...",106,599,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_000362.4,"...m1, amplicon length: 55 and TIMP3: ref. sequence: NM_000362.4, assay ID: Hs00165949_m1, amplicon len...",106,683,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_002332.2,"...gth: 59), lipid metabolism (LRP-1: ref. sequence: NM_002332.2, assay ID: Hs00233856_m1, amplicon len...",106,783,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_002488.2,"...m1, amplicon length: 64 and NDUFA: ref. sequence: NM_002488.2, assay ID: Hs00159575_m1, amplicon len...",106,867,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_003264.3,"...h: 65), and immune response (TLR2: ref. sequence: NM_003264.3, assay ID: Hs00610101_m1, amplicon len...",106,969,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_002046.3,"..., amplicon length: 187) and GAPDH (ref. sequence: NM_002046.3, assay ID: Hs99999905_m1, amplicon len...",106,1164,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_000633.2,"...rent process like apoptosis (BCL2: ref. sequence: NM_000633.2, assay ID: Hs00608023_m1, amplicon len...",123,188,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_078467.1,"...1, amplicon length: 81 and CDKN1A: ref. sequence: NM_078467.1, assay ID: Hs00355782_m1, amplicon len...",123,273,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_002488.2,"...gth: 66), lipid metabolism (NDUFA: ref. sequence: NM_002488.2, assay ID: Hs00159575_m1, amplicon len...",123,373,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_000963.1,"...n length: 65), inflammation (COX2: ref. sequence: NM_000963.1, assay ID: Hs00153133_m1, amplicon len...",123,468,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_004599.2,"... transcription regulation (SREBP2: ref. sequence: NM_004599.2, assay ID: Hs00190237_m1, amplicon len...",123,580,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_004994.2,"...emic control. However, only MMP-9 (ref. sequence: NM_004994.2, assay ID: Hs00234579_m1, amplicon len...",123,759,Cardiovasc_Diabetol_2012_Jul_24_11_86.txt
NM_001033602.2,"...ciated tumour suppressor candidate 2 gene (MTUS2, NM_001033602.2). The same assay was used to confir...",47,662,Case_Rep_Genet_2014_Nov_23_2014_470830.txt
NM_021833.4,"...ll length human UCPs, UCP1 (GenBank accession no. NM_021833.4), UCP2 (GenBank accession no. NM_00335...",30,53,Cell_Calcium_2010_Nov_48(5)_288-301.txt
NM_003355.2,"...ion no. NM_021833.4), UCP2 (GenBank accession no. NM_003355.2) and UCP3 (GenBank accession no. NM_00...",30,95,Cell_Calcium_2010_Nov_48(5)_288-301.txt
NM_003356.3,... no. NM_003355.2) and UCP3 (GenBank accession no. NM_003356.3) were subcloned from previously descri...,30,140,Cell_Calcium_2010_Nov_48(5)_288-301.txt
NM_009654.3,NM_009654.3	CAAGAGTGAGATCGCCCATCG	TTACTTCCTGCACTAA...,85,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_013655.4,NM_013655.4	TGCATCAGTGACGGTAAACCA	TTCTTCAGCCGTGCAA...,88,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_008084.2,NM_008084.2	AGGTCGGTGTGAACGGATTTG	TGTAGACCATGTAGTT...,91,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_010368.1,NM_010368.1	CCGACCTCTCGAACAACCG	GCTTCCCGTTCATACCAC...,94,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_032006.3,NM_032006.3	CCTTGATGAGACGTGGACCAA	ATGTGGTGTTGTTGCA...,97,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_008808.3,NM_008808.3	CGATGAGGACCTGGGCTT	TTCTCGGGCACATGGTTAA...,100,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_009367.3,NM_009367.3	AGAATCGTCCGCTTTGATGTC	TCTGGTTTTCACAACC...,103,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_009368.3,NM_009368.3	CCTATCAGGTCCTGGCACTTT	CTGCCCGGAACAGATT...,106,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_172438.3,NM_172438.3	CTGTGTGCACTTCATGACTCTAAAGA	GAACTCCAGAC...,109,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_009519.2,NM_009519.2	GGTGGTACACCGGCCTATG	TCACTGCCGTTGGAAGTC...,112,2,Cell_Commun_Signal_2014_Nov_7_12_73.txt
NM_001126330.1,...rence Sequence [RefSeq] database accession number NM_001126330.1) using the RNAscope kit (Advanced C...,84,203,Cell_Cycle_2015_Sep_11_14(20)_327015-3281.txt
NM_011486.4,...uplexes of miR-125b-5p and 3′-UTR of mouse STAT3 (NM_011486.4) as predicted by RNA hybrid. (b) Weste...,133,162,Cell_Death_Dis_2013_Dec_12_4(12)_e959.txt
NM_014865.3,[GenBank:NM_014865.3]	C-Nap1	1.89	0.90 ± 0.18	3.13 ± 0.27,157,10,Cell_Div_2014_Sep_25_9_3.txt
NM_002046.3,...rs to amplify the G3PDH gene (983 bp according to NM_002046.3) were used as a control of cDNA abunda...,46,1213,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
NM_053311.1,"PMCA1	F: 5’-CCTGAGGTACCAGAGGCAATAAA-3’	57,71	NM_053311.1",41,46,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_012508.5,"PMCA2	F: 5’-ACCGTGGTGCAGGCCTATGT-3’	56,76	NM_012508.5",43,43,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_133288.1,"PMCA3	F: 5’-AGGCCTGGCAGACAACACCA-3’	57,58	NM_133288.1",45,43,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001110139.2,"SERCA2	F: 5’-TCTGTCATTCGGGAGTGGGG-3’	55,9	NM_001110139.2",49,43,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_012914.1,"SERCA3	F: 5’-CCACCAGGGACACACCCCCA-3’	60,0	NM_012914.1",51,43,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_131907.2,"SPCA1	F: 5’-CCAGTGTGGCCGTGGCTGAC-3’	60,0	NM_131907.2",53,42,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001291454.1,"SPCA2	F: 5’-CCCTTCGCCACTGTATCCAAT-3’	54,4	NM_001291454.1",55,43,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001270779.1,"NCX1	F: 5’-CCCAAGCTTAATGGAGAGACCACCAAGAC-3’	62,9	NM_001270779.1",57,50,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_078619.1,"NCX2	F: 5’-CCCAAGCTTCAGACTGCAAGGAGGGTGTC-3’	65,8	NM_078619.1",59,50,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_078620.2,"NCX3	F: 5’-CCCAAGCTTCAGACTGCAAGGAGGGTGTC-3’	65,7	NM_078620.2",61,50,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_053558.1,"TRPC1	F: 5’-CACAGTGGGCTTGGCCGGAG-3’	60,0	NM_053558.1",63,42,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_021771.2,"TRPC3	F: 5’-GGCACAAGGCGTCGCTGAGT-3’	57,9	NM_021771.2",65,42,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_053559.1,"TRPC6	F: 5’-GGGGACCTCGCTCGTCCGAA-3’	60,0	NM_053559.1",67,42,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_012918.3,"CACNA1a	F: 5’-GCCCGGAGCGCAGAGGATGTA-3’	60,2	NM_012918.3",69,45,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_147141.1,"CACNA1b	F: 5’-CAGCCCCATGTCTGCTGCCAA-3’	58,3	NM_147141.1",71,45,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_012517.2,"CACNA1c	F: 5’-GCATCTCCATCACCTTCTTC-3’	51,8	NM_012517.2",73,44,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_017298.1,"CACNA1d	F: 5’-CTACAGGCGGGATTAAGGAC-3’	53,8	NM_017298.1",75,44,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_153814.1,"CACNA1h	F: 5’-CAGCGCCGGTGAGAGCTTCC-3’	60,0	NM_153814.1",77,44,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001108496.2,"STIM1	F: 5’-TGCGCTCGTCTTGCCCTGTG-3’	57,9	NM_001108496.2",79,42,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001013982.1,"ORAI1	F: 5’-CACCGTCATCGGGACGCTGC-3’	60,0	NM_001013982.1",81,42,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001106398.1,"MCU	F: 5’-AGTACGGTTGTCCCTCTGATG-3’	56,7	NM_001106398.1",83,41,Cell_Tissue_Res_2016_Dec_21_363_609-620.txt
NM_001146038.1,...12656 for osteonectin; NM_013414 for osteocalcin; NM_001146038.1 for Runx2; NM_130458.3 for osterix ...,38,759,Chin_Med_2012_Apr_30_7_10.txt
NM_130458.3,...013414 for osteocalcin; NM_001146038.1 for Runx2; NM_130458.3 for osterix and NR_003286 for 18 S rRN...,38,785,Chin_Med_2012_Apr_30_7_10.txt
NM_000261.1,MYOC	NM_000261.1	Forward: 5’-AGACACCGGATATGGAGAAC-3’,20,6,Chin_Med_J_(Engl)_2016_Aug_20_129(16)_2001-2004.txt
NM_001195057.1,CHOP	NM_001195057.1	Forward: 5’-CAACTGCAGAGATGGCAGCTA-3...,22,6,Chin_Med_J_(Engl)_2016_Aug_20_129(16)_2001-2004.txt
NM_000657.2,BCL-2	NM_000657.2	Forward: 5’-ATGTGTGTGGAGAGCGTCAA-3’,24,7,Chin_Med_J_(Engl)_2016_Aug_20_129(16)_2001-2004.txt
NM_032991.2,Caspase-3	NM_032991.2	Forward: 5’-AGGTATCCATGGAGAACACTG-3’;,26,11,Chin_Med_J_(Engl)_2016_Aug_20_129(16)_2001-2004.txt
XM_006715764.1,β-actin	XM_006715764.1	Forward: 5’-CTGGCACCACACCTTCTACAATG...,28,9,Chin_Med_J_(Engl)_2016_Aug_20_129(16)_2001-2004.txt
NM_199027.2,"(NP_950192.2); mRNA: Zfp335 (NM_199027.2), Ankle2 (NM_001253814.1), Cnpy",1330,30,eLife_3_e03549.txt
NM_001253814.1,"...NP_950192.2); mRNA: Zfp335 (NM_199027.2), Ankle2 (NM_001253814.1), Cnpy",1330,52,eLife_3_e03549.txt
NM_019953.1,"(NM_019953.1), Nme6 (NM_018757.1), Sep15 (NM_053102...",1331,2,eLife_3_e03549.txt
NM_018757.1,"(NM_019953.1), Nme6 (NM_018757.1), Sep15 (NM_053102.2), Tbck (NM_001163...",1331,22,eLife_3_e03549.txt
NM_053102.2,"(NM_019953.1), Nme6 (NM_018757.1), Sep15 (NM_053102.2), Tbck (NM_001163455.1), Wdr4",1331,43,eLife_3_e03549.txt
NM_001163455.1,"...), Nme6 (NM_018757.1), Sep15 (NM_053102.2), Tbck (NM_001163455.1), Wdr4",1331,63,eLife_3_e03549.txt
NM_181400.3,(NM_181400.3),1332,2,eLife_3_e03549.txt
NM_004562.2,...da). Coding DNA mutation numbering is relative to NM_004562.2.,26,836,Curr_Genomics_2015_Aug_16(4)_215-223.txt
NM_004562.2,NM_004562.2 	PRIMER 3+ 	181 bp,91,1,Curr_Genomics_2015_Aug_16(4)_215-223.txt
NM_004562.2,NM_004562.2 	PRIMER 3+ 	123 bp,95,1,Curr_Genomics_2015_Aug_16(4)_215-223.txt
NM_004562.2,NM_004562.2 	PRIMER 3+ 	167 bp,99,1,Curr_Genomics_2015_Aug_16(4)_215-223.txt
NM_000684.2,"... on the corresponding codon in GRCh38 and RefSeq (NM_000684.2), whereas it is Arg in UniProt (access...",99,427,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_005242.4,"...in both the UniProt entry P55085 and RefSeq entry NM_005242.4, whose 30th codon is AAT, but the corr...",101,147,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_014298.3,"...inic acid phosphoribosyltransferase (QPRT, RefSeq NM_014298.3, UniProt Q15274, Figure 4A and B). The...",108,83,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_014298.3,"...rence, rare) to Ala (alternative, major). RefSeq (NM_014298.3, which is now updated to NM_014298.4 w...",108,397,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_014298.4,"...or). RefSeq (NM_014298.3, which is now updated to NM_014298.4 without changing its CDS sequence) and...",108,434,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_004838.3,"..., rare) to Arg (alternative, major). Both RefSeq (NM_004838.3) and UniProt (Q9NSC5) have Ser at this...",114,797,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_031968.2,"...s called exonization, and only isoform 2 of NARF (NM_031968.2) includes this exon. The bases at thre...",121,612,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_031968.2,"...s in GRCh38, but the corresponding ones in RefSeq NM_031968.2 are Gs. The variants corresponding to ...",121,780,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_031968.2,... three base differences between GRCh38 and RefSeq NM_031968.2 are the result of an RNA-editing proce...,121,1524,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_031968.2,"...r regions surrounding discordant variants for (A) NM_031968.2 (NARF), (B) NM_000828.4 (GRIA3) and NM...",122,125,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_000828.4,"...scordant variants for (A) NM_031968.2 (NARF), (B) NM_000828.4 (GRIA3) and NM_000829.3 (GRIA4). A, T,...",122,149,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_000829.3,"...) NM_031968.2 (NARF), (B) NM_000828.4 (GRIA3) and NM_000829.3 (GRIA4). A, T, G and C bases are colou...",122,173,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_000828.4,"... acid receptor ionotropic AMPA (GRIA), the GRIA3 (NM_000828.4) and GRIA4 (NM_000829.3) genes (Figure...",127,107,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_000829.3,"...c AMPA (GRIA), the GRIA3 (NM_000828.4) and GRIA4 (NM_000829.3) genes (Figure 5B and C). The four GRI...",127,131,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_020469.2,...transferase) (abo)	1	chr9	−	133257521:133257521	G	NM_020469.2,139,167,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001080427.1,...aining 7b (thsd7b)	1	chr2	+	137451025:137563217	T	NM_001080427.1,140,93,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001145051.2,...rotein 247 (tmem247)	1	chr2	+	46484425:46484425	A	NM_001145051.2,141,74,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001276254.2,...pseudogene) (ifnl4)	1	chr19	−	39248513:39248515	C	NM_001276254.2,142,84,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001278425.1,"...e 1-like 2 (pkd1l2)	1	chr16	−	81127878:81127878	G	NM_001278425.1, NM_052892.3",143,82,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_052892.3,"...l2)	1	chr16	−	81127878:81127878	G	NM_001278425.1, NM_052892.3",143,98,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_007121.5,"... member 2 (nr1h2)	3	chr19	+	50378567:50378567	ACA	NM_007121.5, NM_001256647.1",144,95,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001256647.1,"...1h2)	3	chr19	+	50378567:50378567	ACA	NM_007121.5, NM_001256647.1",144,108,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_015120.4,...syndrome 1 (alms1)	3	chr2	+	73385903:73385903	GGA	NM_015120.4,145,65,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_181844.3,"...6, member b (bcl6b)	3	chr17	+	7024730:7024730	CAG	NM_181844.3",146,77,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_002111.7,...	Huntingtin (htt)	6	chr4	+	3074935:3074935	GCAGCA	NM_002111.7,147,54,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001289974.1,...beta-like 1 (lactbl1)	7	chr1	−	22965430:-	ATGAAGA	NM_001289974.1,148,70,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_130464.2,"...1404379:21404384, 21404506:21404509	AGCTC, GCTCAC	NM_130464.2",149,138,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_000597.2,...a (igfbp2)	9	chr2	+	216633587:216633587	CGCTGCTGC	NM_000597.2,150,108,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_053005.5,...ivator 2 (mob2)	16	chr11	−	1480886:-	ATGGACTGGCTC	NM_053005.5,151,70,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_152503.5,"...(mroh8)	29	chr20	−	37179390:37179390	AAGAGTGCCGGC	NM_152503.5, NM_213631.2, NM_213632.2",153,98,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_213631.2,"...r20	−	37179390:37179390	AAGAGTGCCGGC	NM_152503.5, NM_213631.2, NM_213632.2",153,111,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_213632.2,"...0:37179390	AAGAGTGCCGGC	NM_152503.5, NM_213631.2, NM_213632.2",153,124,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_012234.6,... protein (rybp)	30	chr3	−	72446623:-	ATGACCATGGGC	NM_012234.6,155,77,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001159995.1,"...uregulin 1 (nrg1)hrg-beta1	35	chr8	+	−:32595825	–	NM_001159995.1, NM_001159999.1",157,58,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001159999.1,"...)hrg-beta1	35	chr8	+	−:32595825	–	NM_001159995.1, NM_001159999.1",157,74,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_033517.1,...domains 3 (shank3)	42	chr22	+	50695048:50697563	–	NM_033517.1,158,90,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_012115.3,"...rotein 2 (casp8ap2)	48	chr6	+	89871390:89873802	–	NM_012115.3, NM_001137667.1, NM_001137668.1",159,82,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001137667.1,"...p8ap2)	48	chr6	+	89871390:89873802	–	NM_012115.3, NM_001137667.1, NM_001137668.1",159,95,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_001137668.1,"...	89871390:89873802	–	NM_012115.3, NM_001137667.1, NM_001137668.1",159,111,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_182705.2,"...ty 101, member b (fam101b)	209	chr17	−	445940:-	–	NM_182705.2",160,88,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_017940.4,"...reakpoint family, member 1 (nbpf1)	220	chr1	−	–	–	NM_017940.4",161,72,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_138352.1,...taining 1 (samd1)	318	chr19	−	14090084:14090084	–	NM_138352.1,162,87,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_173600.2,"...UC19	Mucin 19, oligomeric (muc19)	487	chr12	+	–	–	NM_173600.2",163,52,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_002457.3,...gomeric mucus/gel-forming (muc2)	3153	chr11	+	–	–	NM_002457.3,164,68,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_003890.2,...t of igg binding protein (fcgbp)	3603	chr19	−	–	–	NM_003890.2,165,67,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
NM_015120.4,"...databases. For example, the ALMS1 mRNA in RefSeq (NM_015120.4) has a tandem repeat of thirteen GAG c...",174,563,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
XM_002718254.1,...es 408 to 1181 of the published sequence; GenBank XM_002718254.1 and Ensembl ENSOCUT00000011093; cal...,24,309,Dev_Genes_Evol_2011_Oct_1_221(4)_209-223.txt
NM_001082650.1,"...ther the published sequence (rabbit BMP2, GenBank NM_001082650.1) or aligned cDNA sequences of human...",28,53,Dev_Genes_Evol_2011_Oct_1_221(4)_209-223.txt
NM_001082650.1,"...s: BMP2 (875 bp; nucleotides 219–1,093 of GenBank NM_001082650.1): 5′-CGAGTTCGAGTTGCGGTTGC-3′ (forwa...",28,876,Dev_Genes_Evol_2011_Oct_1_221(4)_209-223.txt
NM_001082650.1,"...lues of homology (99.7% with rabbit BMP2, GenBank NM_001082650.1; 98.8% with a predicted rabbit BLIM...",28,1406,Dev_Genes_Evol_2011_Oct_1_221(4)_209-223.txt
NM_001082650.1,"...ein coding part of the rabbit cDNAs—GenBank entry NM_001082650.1 and XM_002718254.1), false cross hy...",76,190,Dev_Genes_Evol_2011_Oct_1_221(4)_209-223.txt
XM_002718254.1,"...the rabbit cDNAs—GenBank entry NM_001082650.1 and XM_002718254.1), false cross hybridization of our ...",76,209,Dev_Genes_Evol_2011_Oct_1_221(4)_209-223.txt
NM_002046.4,AA-3’	NM_002046.4	458	55,32,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NR_003286.2,CG-3’	NR_003286.2	68	66,37,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_021101.4,Claudin 1	5'-TCA CTC CCA GGA GGA TGC-3'	NM_021101.4	99	59,41,41,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_020384.3,TGA CTT CTC TC-3'	NM_020384.3	100	59,46,19,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_001306.3,-3'	NM_001306.3	98	57,51,5,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_001305.3,CG-3'	NM_001305.3	103	58,56,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_003277.3,T-3'	NM_003277.3	130	59,61,6,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_021195.4,TAT-3'	NM_021195.4	94	59,66,8,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_001307.5,G-3'	NM_001307.5	101	57,71,6,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_199328.2,GA-3'	NM_199328.2	108	58,76,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_020982.3,GC-3'	NM_020982.3	90	60,81,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_006984.4,-3'	NM_006984.4	91	55,85,5,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_005602.5,GA-3'	NM_005602.5	100	57,90,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_012129.4,TGA-3'	NM_012129.4	106	57,95,8,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_144492.2,AT-3'	NM_144492.2	115	57,100,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_014343.2,-3'	NM_014343.2	110	58,105,5,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_006580.3,AT-3'	NM_006580.3	95	56,110,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_002538.3,GA-3'	NM_002538.3	102	58,115,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_016946.4,GG-3'	NM_016946.4	109	57,120,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_021219.3,AG-3'	NM_021219.3	121	57,125,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_032801.4,GGG-3'	NM_032801.4	90	57,129,8,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_003257.3,GA-3'	NM_003257.3	96	58,134,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_201629.3,AT-3'	NM_201629.3	110	58,139,7,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_001267561.1,TJP3	5'-CAC TGT CCA AGG ACC CCC-3'	NM_001267561.1	100	61,143,36,Dev_Reprod_2014_Dec_18(4)_213-224.txt
NM_001163291.1,"...is given according to the NCBI reference sequence NM_001163291.1 (Monk et al., 2009)",33,643,Development_2013_Nov_1_140(21)_4362-4374.txt
NM_001039510.1,...mer spans exons 1 and 3 of the mouse Adora1 gene (NM_001039510.1). This assay amplified only the pro...,38,557,Diabetes_2013_Dec_16_62(12)_4208-4219.txt
NM_000674.2,...splice variant lacking exon 3 of the ADORA1 gene (NM_000674.2). Primers targeting only exon 3 were d...,47,326,Diabetes_2013_Dec_16_62(12)_4208-4219.txt
NM_015226.2,"...II-BQ221200, CIITA IV-BM147267, CLEC16A Isoform I-NM_015226.2, CLEC16A Isoform II-BC112897.1, CLEC16...",51,458,Diabetes_2014_Dec_13_63(12)_4360-4368.txt
NM_014015.3,"...-BC112897.1, CLEC16A Isoform III-AK126771.1, DEXI-NM_014015.3, SOCS1-NM_003745.1, GAPDH- NM_002046.3...",51,539,Diabetes_2014_Dec_13_63(12)_4360-4368.txt
NM_003745.1,"...A Isoform III-AK126771.1, DEXI-NM_014015.3, SOCS1-NM_003745.1, GAPDH- NM_002046.3) using Primer3 (48...",51,558,Diabetes_2014_Dec_13_63(12)_4360-4368.txt
NM_002046.3,"...71.1, DEXI-NM_014015.3, SOCS1-NM_003745.1, GAPDH- NM_002046.3) using Primer3 (48) (Supplementary Tab...",51,578,Diabetes_2014_Dec_13_63(12)_4360-4368.txt
NM_000162.3,...ancreatic β-cell isoform of GCK (accession number NM_000162.3) was sequenced using standard protocol...,28,56,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
NM_004487.3,"...mily b, macrogolgin (with transmembrane signal) 1	NM_004487.3	11 185	3259	ARiS161G17	AB371588	11 198...",92,99,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_018177.2,2	HP07459	N4BP2	Nedd4 binding protein 2	NM_018177.2	6616	1770	ARiS023B20	AB371584	9736	169...,93,41,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_198836.1,...HP08032	ACACA	Acetyl-Coenzyme A carboxylase alpha	NM_198836.1	9585	2346	ARiS088K16	AB371587	9534	234...,94,53,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_001457.2,"...	FLNB	Filamin B, beta (actin binding protein 278)	NM_001457.2	9463	2602	ARe23D04	AB191258	9405	2591",95,60,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_001458.3,"...FLNC	Filamin C, gamma (actin binding protein 280)	NM_001458.3	9146	2725	ARi57A02	AB371585	9156	2725",99,61,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_003128.2,"...HP07744	SPTBN1	Spectrin, beta, non-erythrocytic 1	NM_003128.2	10 238	2364	ARiS088A21	AB371586	8443	2...",100,53,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_001456.2,"...FLNA	Filamin A, alpha (actin binding protein 280)	NM_001456.2	8278	2639	ARe06F05	AB191259	8212	2612",101,62,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_000093.3,"18	HP06504	COL5A1	Collagen, type V, alpha 1	NM_000093.3	8439	1838	ARe79B07	AB371586	8139	1838",109,45,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_006836.1,... control of amino-acid synthesis 1-like 1 (yeast)	NM_006836.1	8699	2671	ARi43H04	—	8.0 k,110,81,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_002840.2,"...RF	Protein tyrosine phosphatase, receptor type, F	NM_002840.2	7718	1897	ARe76H09	—	8.0 k",111,65,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_003127.1,"...pectrin, alpha, non-erythrocytic 1 (alpha-fodrin)	NM_003127.1	7787	2472	ARe45C02	AB191262	7791	2452",112,70,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_212476.1,22	HP00124	FN1	Fibronectin 1	NM_212476.1	8272	2296	ARe05G09	AB191261	7753	2265,113,30,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_006197.3,25	HP06896	PCM1	Pericentriolar material 1	NM_006197.3	8788	2024	ARi07G10	—	7.5 k,116,43,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_001042413.1,26	HP04727	GLIS3	GLIS family zinc finger 3	NM_001042413.1	7656	930	ARe06E05	—	7.5 k,117,44,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_080686.1,27	HP04890	BAT2	HLA-B associated transcript 2	NM_080686.1	6750	2157	ARe17F01	—	7.5 k,118,47,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_019112.2,"...P-binding cassette, sub-family A (ABC1), member 7	NM_019112.2	6704	2146	ARe05B12	—	7.5 k",120,70,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_024949.4,"...5	WWC2	WW, C2 and coiled-coil domain containing 2	NM_024949.4	6492	987	ARi58B08	—	7.5 k",121,60,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_002473.3,"...4667	MYH9	myosin, heavy polypeptide 9, non-muscle	NM_002473.3	7274	1960	ARe01B05	AB191263	7436	1960",122,57,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_198576.2,38	HP04680	AGRN	Agrin	NM_198576.2	7319	2045	ARe02B04	AB191264	7319	2045,129,23,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_006035.2,...BPB	CDC42 binding protein kinase beta (DMPK-like)	NM_006035.2	6782	1711	ARiS023M02	—	7.2 k,131,67,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_001039580.1,41	HP07424	MAP9	microtubule-associated protein 9	NM_001039580.1	7333	647	ARiS109F14	—	7.1 k,132,50,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_005156.4,...D1	ROD1 regulator of differentiation 1 (S. pombe)	NM_005156.4	7230	552	ARi40D10	—	7.0 k,133,64,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_012288.3,...TRAM2	Translocation associated membrane protein 2	NM_012288.3	7065	370	ARi50G08	—	7.0 k,134,62,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_001845.4,"44	HP06927	COL4A1	Collagen, type IV, alpha 1	NM_001845.4	6549	1669	ARe94G08	—	7.0 k	c",135,46,DNA_Res_2008_Jun_16_15(3)_123-136.txt
XM_290799.7,...HP07685	ARHGAP23	Rho GTPase activating protein 23	XM_290799.7	6475	1684	ARi70H06	—	7.0 k,137,54,DNA_Res_2008_Jun_16_15(3)_123-136.txt
XM_371474.4,47	HP02917	PLXNB2	Plexin B2	XM_371474.4	6434	1901	ARe49A01	—	7.0 k	c,138,29,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_020918.3,"...ycerol-3-phosphate acyltransferase, mitochondrial	NM_020918.3	6386	828	ARi06G08	—	7.0 k",139,69,DNA_Res_2008_Jun_16_15(3)_123-136.txt
NM_006029.4,Human	hsPNMA1	PNMA1	NM_006029.4	chr.14:74178486-74181128,40,21,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_007257.5,hsPNMA2	PNMA2	NM_007257.5	chr.8:26362196-26371483,41,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_013364.4,hsPNMA3	PNMA3	NM_013364.4	chr.X:152224766-152228827,42,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_022151.4,hsPNMA4	PNMA4	NM_022151.4	chr.14:93648541-93651249,43,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_052926.2,hsPNMA5	PNMA5	NM_052926.2	chr.X:152157368-152162671,44,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_032882.4,hsPNMA6A	PNMA6A	NM_032882.4	chr.X:152338301-152340107,45,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
XM_002343859.2,hsPNMA6B	PNMA6B	XM_002343859.2	chr.X:152341614-152342813,46,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
XM_002343858.2,hsPNMA6D	PNMA6D	XM_002343858.2	chr.X:152244152-152246070,47,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001170944.1,hsPNMA6C	PNMA6C	NM_001170944.1	chr.X:152240819-152243402,48,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
XM_938309.4,hsPNMA8	LOC649238	XM_938309.4	chr.X:152662364-152663269,50,19,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_173798.2,hsPNMA10	ZCCHC12	NM_173798.2	chr.X:117957787-117960931,52,18,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001143978.1,hsPNMA11	ZCCHC18	NM_001143978.1	chr.X:103357107-103360533,53,18,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001103149.1,hsPNMA12	PNMAL1	NM_001103149.1	chr.19:46969748-46974820,54,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_020709.1,hsPNMA13	PNMAL2	NM_020709.1	chr.19:46994448-46999169,55,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_032040.3,hsPNMA14	CCDC8	NM_032040.3	chr.19:46913586-46916919,56,16,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_027438.3,Mouse	mmPNMA1	Pnma1	NM_027438.3	chr.12:85487081-85489439,59,21,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_175498.4,mmPNMA2	Pnma2	NM_175498.4	chr.14:67530045-67538898,60,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_153169.2,mmPNMA3	Pnma3	NM_153169.2	chr.X:70310126-70313530,61,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001142937.1,mmPNMA4	Pnma4	NM_001142937.1	chr.12:103978040-103981870,62,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001100461.3,mmPNMA5	Pnma5	NM_001100461.3	chr.X:70279327-70282442,63,15,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_028325.3,mmPNMA10	Zcchc12	NM_028325.3	chr.X:33735899-33739153,67,18,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001035509.1,mmPNMA11	Zcchc18	NM_001035509.1	chr.X:133527694-133531462,68,18,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001007569.1,mmPNMA12	PNMAL1	NM_001007569.1	chr.7:17545144-17547669,69,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001099636.2,mmPNMA13	PNMAL2	NM_001099636.2	chr.7:17530031-17532427,70,17,DNA_Res_2013_Oct_23_20(5)_425-436.txt
NM_001101535.1,mmPNMA14	CCDC8	NM_001101535.1	chr.7:17579937-17581994,71,16,DNA_Res_2013_Oct_23_20(5)_425-436.txt
XM_415902.2,...0.01	0.13	NA	NA	0.50	0.43	1.00	1	gi|118100421|ref|XM_415902.2|	DUSP14 dual specificity phosphatase 1...,100,58,Ecol_Evol_2012_Oct_31_2(10)_2485-2505.txt
NM_001159347.1,...0.05	0.14	NA	NA	0.38	0.29	0.94	0	gi|226823205|ref|NM_001159347.1|	neuron navigator 3,105,58,Ecol_Evol_2012_Oct_31_2(10)_2485-2505.txt
NM_001030907.1,...	0.09	0.17	NA	NA	0.40	0.33	0.99	1	gi|71897262|ref|NM_001030907.1	RCAN family member 3,133,57,Ecol_Evol_2012_Oct_31_2(10)_2485-2505.txt
NM_001030906.1,"...4	0.03	6.16	0.05	0.60	0.30	0.94	0	gi|71897266|ref|NM_001030906.1|	splicing factor, arginine/serine-r...",167,61,Ecol_Evol_2012_Oct_31_2(10)_2485-2505.txt
NM_001077499.2,"... (Mus musculus, mNav 1.1, NP_061203 and mNav 1.6, NM_001077499.2); murine voltage-gated Cav channels...",292,1431,eLife_4_e07624.txt
NM_001112739.1,"...ker, CAA29917.1) and mouse (Mus musculus, mKv3.1, NM_001112739.1)",292,1692,eLife_4_e07624.txt
NM_010260.1,"... WT ORF of mGBP2 (NCBI accession numbers: mGBP-2, NM_010260.1) was subjected to site directed mutage...",306,54,eLife_5_e11479.txt
NM_010259.2,"...r GFP by the gene for mCherry. The ORFs of mGBP1 (NM_010259.2), mGBP2, mGBP3 (NM_001289492.1), mGBP5...",306,614,eLife_5_e11479.txt
NM_001289492.1,"...y. The ORFs of mGBP1 (NM_010259.2), mGBP2, mGBP3 (NM_001289492.1), mGBP5 (NM_153564.2), mGBP6 (NM_19...",306,642,eLife_5_e11479.txt
NM_153564.2,"..._010259.2), mGBP2, mGBP3 (NM_001289492.1), mGBP5 (NM_153564.2), mGBP6 (NM_194336.2) were then cloned...",306,666,eLife_5_e11479.txt
NM_194336.2,"...BP3 (NM_001289492.1), mGBP5 (NM_153564.2), mGBP6 (NM_194336.2) were then cloned into the modified pW...",306,687,eLife_5_e11479.txt
NM_000350.2,"...DNA stuffer sequence of 3632 bp from human ABCA4 (NM_000350.2, bp 1960-5591) upstream of the CMV pro...",136,1033,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_007378.1,"...r sequence of 3621 bp, composed of: murine ABCA4 (NM_007378.1, 1066-1 and 7124-6046 bp; 2145 total b...",136,1162,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_153676.3,"... 7124-6046 bp; 2145 total bp) and human Harmonin (NM_153676.3 131-1606 bp; 1476 total bp), downstrea...",136,1235,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000350.2,"...asmids contained the full-length human ABCA4 CDS (NM_000350.2, bp 105-6926), while the oversize MYO7...",138,72,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000260.3,"...d the full-length human MYO7A CDS from isoform 1 (NM_000260.3, bp 273-6920). To generate plasmids fo...",138,191,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000350.2,"...onstructs, one containing N-terminal CDS ( ABCA4: NM_000350.2, bp 105-3588; MYO7A: NM_000260.3, bp 2...",138,358,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000260.3,"...nal CDS ( ABCA4: NM_000350.2, bp 105-3588; MYO7A: NM_000260.3, bp 273-3782) and the other containing...",138,391,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000350.2,"... and the other containing C-terminal CDS ( ABCA4: NM_000350.2, bp 2819-6926; MYO7A: NM_000260.3, bp ...",138,466,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000260.3,"...al CDS ( ABCA4: NM_000350.2, bp 2819-6926; MYO7A: NM_000260.3, bp 2913-6920). Therefore, the region ...",138,500,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000350.2,"...on. ABCA4 was split between exons 19-20 (5′ half: NM_000350.2, 105-3022 bp; 3′ half: NM_000350.2, bp...",138,811,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000350.2,"...9-20 (5′ half: NM_000350.2, 105-3022 bp; 3′ half: NM_000350.2, bp 3023-6926) and MYO7A was split bet...",138,846,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000260.3,"...and MYO7A was split between exons 24-25 (5′ half: NM_000260.3, bp 273-3380; 3′ half: NM_000260.3, bp...",138,923,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_000260.3,"...4-25 (5′ half: NM_000260.3, bp 273-3380; 3′ half: NM_000260.3, bp 3381-6926). The ABCA4 and MYO7A pr...",138,958,EMBO_Mol_Med_2014_Feb_16_6(2)_194-211.txt
NM_024022.2,"...7, rs397517376), we assume that they refer to the NM_024022.2 and NP_076927.1 sequences at the mRNA ...",10,294,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
NM_024022.2,"...ation). Furthermore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_0...",10,965,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
NM_024022.2,...ns (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were de...,10,1011,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
NM_021994.2,"...us microdeletion of 21,379 bp in the ZNF277 gene (NM_021994.2), encompassing exon 5, in an individua...",5,604,Eur_J_Hum_Genet_2014_Oct_12_22(10)_1165-1171.txt
NM_021994.2,"...ozygous microdeletion involving exon 5 of ZNF277 (NM_021994.2) (chr7:g111955948_111960100del, hg19)....",24,524,Eur_J_Hum_Genet_2014_Oct_12_22(10)_1165-1171.txt
NM_000181.3,"..._111470446del, hg19). The housekeeping gene GUSB (NM_000181.3) was used as a normalizer and expressi...",47,571,Eur_J_Hum_Genet_2014_Oct_12_22(10)_1165-1171.txt
NM_021994.2,...and introducing a premature stop codon in exon 7 (NM_021994.2). Given the likelihood of non-sense-me...,51,293,Eur_J_Hum_Genet_2014_Oct_12_22(10)_1165-1171.txt
NM_001002294.2,...NG_012690.1 and the transcript reference sequence NM_001002294.2. Causative sequence variants are po...,21,367,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
NM_000492.3,"... initiation codon in the CFTR reference sequence (NM_000492.3), with initiation codon as codon 1 and...",20,739,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
NM_022437.2,...t LD with the previously reported rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amin...,92,752,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
NM_022437.2,"... effect, possibly reflecting an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 b...",92,1050,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
NM_022436.2,"...G5, rs10439467:C>T in intron 10 and rs6720173:G>C NM_022436.2(ABCG5)c.1810C>G (p.Gln604Glu). The ABC...",92,1275,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
NM_001009465.2,IL1B	AGCCCGTCTTCCTGGGACGTT	98	NM_001009465.2,94,31,Eur_Spine_J_2012_Sep_29_21(9)_1758-1768.txt
NM_001206633.1,PRG4 (Bos Taurus)	ACCTCCACCTCGGAGAATTACT	88	NM_001206633.1,96,45,Eur_Spine_J_2012_Sep_29_21(9)_1758-1768.txt
NM_001009784.1,ACTIN	ACGGGCAGGTCATCACCAT	95	NM_001009784.1,98,30,Eur_Spine_J_2012_Sep_29_21(9)_1758-1768.txt
NM_001190390.1,GAPDH	TGACCCCTTCATTGACCTTCAC	94	NM_001190390.1,100,33,Eur_Spine_J_2012_Sep_29_21(9)_1758-1768.txt
NM_011038.2,Pax-4	NM_011038.2	TGGCTTCCTGTCCTTCTGTGAGG	TCCAAGACTCCTGT...,252,7,Evid_Based_Complement_Alternat_Med_2013_Apr_15_2013_280392.txt
NM_144955.2,Nkx-6.1	NM_144955.2	ATGGGAAGAGAAAACACACCAGAC	TAATCGTCGTCGT...,253,9,Evid_Based_Complement_Alternat_Med_2013_Apr_15_2013_280392.txt
NM_008386.3,Insulin	NM_008386.3	GCCCAGGCTTTTGTCAAACA	CTCCCCACACACCAGGT...,254,9,Evid_Based_Complement_Alternat_Med_2013_Apr_15_2013_280392.txt
NM_008100.3,Glucagon	NM_008100.3	ATGAAGACCATTTACTTTGTGGCT	GGTGTTCATCAAC...,255,10,Evid_Based_Complement_Alternat_Med_2013_Apr_15_2013_280392.txt
NM_009042.1,Reg-1	NM_009042.1	AAGCTGAAGAAGACCTGCCA	TGTTAGGAGACCCAGTT...,256,7,Evid_Based_Complement_Alternat_Med_2013_Apr_15_2013_280392.txt
NM_011331.2,MCP-1	NM_011331.2	Forward	5′-TTAAAAACCTGGATCGGAACCAA-3′,98,7,Exp_Mol_Med_2013_Jan_10_45(1)_e4.txt
NM_028075.2,BAFF-R	NM_028075.2	Forward	5′-GACCCTGGTGGGTCTAGTGA-3′,106,8,Exp_Mol_Med_2013_Jan_10_45(1)_e4.txt
NM_011608.1,BCMA	NM_011608.1	Forward	5′-ATCTTCTTGGGGCTGACCTT-3′,108,6,Exp_Mol_Med_2013_Jan_10_45(1)_e4.txt
NM_021349.1,TACI	NM_021349.1	Forward	5′-CTACTGCACACTGGGGGTCT-3′,110,6,Exp_Mol_Med_2013_Jan_10_45(1)_e4.txt
NM_176875.2,"... in the human 14-3-3ζ gene (GenBank Accession No. NM_176875.2), and one of these vectors was selecte...",27,307,Exp_Mol_Med_2014_Feb_21_46(2)_e77.txt
NM_022459.4,...ntrol. The primers were as follows: XPO4 (Genbank NM_022459.4) forward primer 5′-TTGTTCTTGGTGTTTTGTG...,26,650,Exp_Ther_Med_2013_Jan_16_5(1)_119-127.txt
NM_000660.3,...r 5′-CATTCCTTTCCCACTCCTCTT TAG-3′; TGFβ1 (Genbank NM_000660.3) forward primer 5′-GCAACAATTCCTGGCGATA...,26,776,Exp_Ther_Med_2013_Jan_16_5(1)_119-127.txt
NM_001039667.1,... 5′-CAGTGTGTTATCCCTGCTGTCACA-3′; ANGPTL4 (Genbank NM_001039667.1) forward primer 5′-GACCAA GGGGCATGG...,26,901,Exp_Ther_Med_2013_Jan_16_5(1)_119-127.txt
NM_020390.5,...GGG ACC TACACACA ACAG CA-3′; el F5A 2 (G enba n k NM_020390.5) forward primer 5′-TTGTTCTCAGGG CTATTT...,26,1035,Exp_Ther_Med_2013_Jan_16_5(1)_119-127.txt
NM_002046.3,...GGATGCTAC TGTTTCCATTTTTTTC-3′; and GAPDH (Genbank NM_002046.3) forward primer 5′-TCCCTCAACATTGTC AGC...,26,1168,Exp_Ther_Med_2013_Jan_16_5(1)_119-127.txt
NM_001101683.1,β-actin	GTGAGATGCCATGTGACGGA	TACACAAATGCGATGCTGCC	NM_001101683.1,89,51,Exp_Ther_Med_2014_Feb_15_7(2)_329-334.txt
NM_001082203.1,MMP-9	GGGCTACGTGAGCTTTGACA	AAACTGGTCCCTTCCCCGTC	NM_001082203.1,90,49,Exp_Ther_Med_2014_Feb_15_7(2)_329-334.txt
NM_001082232.2,TIMP-1	CCGGACAGACGCTAGAGAATC	AAGGTCGGAGTTGCAGAAGG	NM_001082232.2,91,51,Exp_Ther_Med_2014_Feb_15_7(2)_329-334.txt
NM_001082388.1,COX-2	TGAACTTCCAAGCTGGCCTC	CCGATGCACAACTGAACTGG	NM_001082388.1,92,49,Exp_Ther_Med_2014_Feb_15_7(2)_329-334.txt
NM_001082277.1,...ned from the Ldh-a gene of Oryctolagus cuniculus (NM_001082277.1). The pika Ldh-b specific primers f...,25,115,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_008492.2,"...quence regions of the Ldh-b gene of Mus musculus (NM_008492.2), Homo sapiens (NM_002300.5), Bos taur...",25,298,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_002300.5,"...gene of Mus musculus (NM_008492.2), Homo sapiens (NM_002300.5), Bos taurus (NM_174100.1) and Rattus ...",25,326,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_174100.1,"...08492.2), Homo sapiens (NM_002300.5), Bos taurus (NM_174100.1) and Rattus norvegicus (NM_012595.1). ...",25,352,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_012595.1,"..., Bos taurus (NM_174100.1) and Rattus norvegicus (NM_012595.1). For Ldh-c, the specific primer for 5...",25,388,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_013580.4,"...equence regions of the Ldh-c gene of M. musculus (NM_013580.4), H. sapiens (NM_002301.4), B. taurus ...",25,568,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_002301.4,"...-c gene of M. musculus (NM_013580.4), H. sapiens (NM_002301.4), B. taurus (NM_001113249.1) and R. no...",25,594,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_001113249.1,"...M_013580.4), H. sapiens (NM_002301.4), B. taurus (NM_001113249.1) and R. norvegicus (NM_017266.2)",25,619,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_017266.2,"...4), B. taurus (NM_001113249.1) and R. norvegicus (NM_017266.2)",25,654,FEBS_Open_Bio_2013_Feb_4_3_118-123.txt
NM_053356.1,"...rat were designed according to GenBank sequences (NM_053356.1, NM_032085.1, NM_053819.1, NM_021989.2...",106,960,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_032085.1,"...gned according to GenBank sequences (NM_053356.1, NM_032085.1, NM_053819.1, NM_021989.2, NM_031054.2...",106,973,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_053819.1,"...g to GenBank sequences (NM_053356.1, NM_032085.1, NM_053819.1, NM_021989.2, NM_031054.2, NM_031055.1...",106,986,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_021989.2,"...sequences (NM_053356.1, NM_032085.1, NM_053819.1, NM_021989.2, NM_031054.2, NM_031055.1 and NM_01258...",106,999,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_031054.2,"..._053356.1, NM_032085.1, NM_053819.1, NM_021989.2, NM_031054.2, NM_031055.1 and NM_012583.2, respecti...",106,1012,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_031055.1,"..._032085.1, NM_053819.1, NM_021989.2, NM_031054.2, NM_031055.1 and NM_012583.2, respectively) and pro...",106,1025,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_012583.2,"...3819.1, NM_021989.2, NM_031054.2, NM_031055.1 and NM_012583.2, respectively) and probes were designe...",106,1041,Fibrogenesis_Tissue_Repair_2011_Aug_3_4_19.txt
NM_008084.2,Glyceraldehyde-3-phosphate dehydrogenase	GAPDH	NM_008084.2	60	140	330001-PPM02946E,67,48,Front_Bioeng_Biotechnol_2015_Feb_3_2_85.txt
NM_011443.3,SRY-box containing gene 2	SOX2	NM_011443.3	60	110	330001-PPM04762E,68,32,Front_Bioeng_Biotechnol_2015_Feb_3_2_85.txt
NM_007770.4,Cone-rod homeobox containing gene	CRX	NM_007770.4	60	191	330001-PPM25460A,69,39,Front_Bioeng_Biotechnol_2015_Feb_3_2_85.txt
NM_008398.2,Integrin alpha 7	ITGA7	NM_008398.2	60	182	330001-PPM03611E,70,24,Front_Bioeng_Biotechnol_2015_Feb_3_2_85.txt
NM_016780.2,Integrin beta 3	ITGB3	NM_016780.2	60	67	330001-PPM03687E,71,23,Front_Bioeng_Biotechnol_2015_Feb_3_2_85.txt
NM_031743.2,The full length rat NCKX2 (NM_031743.2; O54701) was cloned into pcDNA3.1(+) p...,24,28,Front_Cell_Neurosci_2013_Feb_20_7_14.txt
NM_053837.1,"...o Alto, CA, USA). The HA-tagged AP2M1 (HA-AP2M1) (NM_053837.1; P84092) cloned into pcDNA3 and non-ta...",24,642,Front_Cell_Neurosci_2013_Feb_20_7_14.txt
NM_021488.4,"...mplify the transcripts for ghrelin (Accession No. NM_021488.4, 32 cycles, 329 bps), GOAT (Accession ...",52,391,Front_Endocrinol_(Lausanne)_2013_Jul_9_4_84.txt
XM_003438349.1,...translated regions. (B) The lhb genes of tilapia (XM_003438349.1) and zebrafish (NM_205622.2) differ...,56,334,Front_Endocrinol_(Lausanne)_2014_Oct_22_5_182.txt
NM_205622.2,... genes of tilapia (XM_003438349.1) and zebrafish (NM_205622.2) differ in size and in exon–intron num...,56,365,Front_Endocrinol_(Lausanne)_2014_Oct_22_5_182.txt
XM_007903550.1,"...) MRAP1 (XR_001470382) elephant shark (es) MRAP1 (XM_007903550.1), mouse (m) MRAP2 (XP_006511239.1),...",36,225,Front_Endocrinol_(Lausanne)_2016_Jun_28_7_79.txt
XM_007903550.1,...enome project1 revealed a cDNA (accession number: XM_007903550.1) that Blast analysis2 has identifie...,50,692,Front_Endocrinol_(Lausanne)_2016_Jun_28_7_79.txt
NM_009463.3,Mouse	mm9	8	X	NM_009463.3	85814247	85822355	+	85811607	85812107	...,167,15,Front_Genet_2013_Jan_3_3_304.txt
NM_145740.3,NM_145740.3:c.-135T>C,186,2,Front_Genet_2014_Nov_14_5_391.txt
NM_174008.1,"CD14, NM_174008.1		CGATTTCCGTTGTGTCTGC	150	(16)",56,7,Front_Immunol_2016_Aug_29_7_322.txt
NM_001077402.1,"CD16α, NM_001077402.1	Low-affinity FcγIIIR	TGTCTCGTCATTCT...",58,8,Front_Immunol_2016_Aug_29_7_322.txt
NM_001102558.2,"CX3CR1, NM_001102558.2	CX3C-chemokine receptor 1	TCACCAGAG...",60,9,Front_Immunol_2016_Aug_29_7_322.txt
NM_001166068.1,"TGFβ1, NM_001166068.1	Transforming growth factor beta 1	C...",64,8,Front_Immunol_2016_Aug_29_7_322.txt
NM_174093.1,"IL-1β, NM_174093.1	Interleukin-1 beta	AAAAATCCCTGGTGCTGGC...",66,8,Front_Immunol_2016_Aug_29_7_322.txt
NM_173923.2,"IL-6, NM_173923.2	Interleukin-6	CCTGAAGCAAAAGATCGCAGA	97...",68,7,Front_Immunol_2016_Aug_29_7_322.txt
NM_174088.1,"IL-10, NM_174088.1	Interleukin-10	TATCCACTTGCCAACCAGCC	15...",70,8,Front_Immunol_2016_Aug_29_7_322.txt
NM_174356.1,"IL-12β, NM_174356.1	Interleukin-12 subunit beta	GAGGTCGTGG...",72,9,Front_Immunol_2016_Aug_29_7_322.txt
NM_173966.3,"TNFα, NM_173966.3	Tumor necrosis factor alpha	TCTTCTCAAG...",74,7,Front_Immunol_2016_Aug_29_7_322.txt
NM_012512.2,B2m	F: GAGCAGGTTGCTCCACAGGT	NM_012512.2,40,29,Front_Immunol_2016_Sep_16_7_361.txt
NM_031116.3,Ccl5	F: CTTGCAGTCGTCTTTGTCACTC	NM_031116.3,42,32,Front_Immunol_2016_Sep_16_7_361.txt
NM_057203.1,Ccl22	F: TGCTTCAGACTTCCTTGGCC	NM_057203.1,44,31,Front_Immunol_2016_Sep_16_7_361.txt
NM_139089.1,Cxcl10	F: TGCAAGTCTATCCTGTCCGC	NM_139089.1,46,32,Front_Immunol_2016_Sep_16_7_361.txt
NM_182952.2,Cxcl11	F: CGGTTCCAGGCTTCGTTATG	NM_182952.2,48,32,Front_Immunol_2016_Sep_16_7_361.txt
NM_012555.2,Ets1	F: ACGACTACCCTTCCGTCATTC	NM_012555.2,50,31,Front_Immunol_2016_Sep_16_7_361.txt
NM_017008.3,Gapdh	F: GGGCTGCCTTCTCTTCTGAC	NM_017008.3,52,31,Front_Immunol_2016_Sep_16_7_361.txt
NM_001025409.1,Hdac1	F: CTCCATCTTCTCTCCAAGTCCCT	NM_001025409.1,54,34,Front_Immunol_2016_Sep_16_7_361.txt
NM_053448.1,Hdac3	F: CTGGGAGGTGGTGGTTACAC	NM_053448.1,56,31,Front_Immunol_2016_Sep_16_7_361.txt
NM_012854.2,IL10	F: CCTCTGGATACAGCTGCGAC	NM_012854.2,58,30,Front_Immunol_2016_Sep_16_7_361.txt
NM_019165.1,IL18	F: ACCTGAAGATAATGGAGACTTGG	NM_019165.1,60,33,Front_Immunol_2016_Sep_16_7_361.txt
NM_001191988.1,IL22	F: TCCAGCAGCCATACATCGTC	NM_001191988.1,62,30,Front_Immunol_2016_Sep_16_7_361.txt
NM_017020.3,Il6r	F: CTATACCCCTGCCCACATTCC	NM_017020.3,64,31,Front_Immunol_2016_Sep_16_7_361.txt
NM_001105721.1,Notch1	F: TCAGCTCCCTGCAAGAATGG	NM_001105721.1,66,32,Front_Immunol_2016_Sep_16_7_361.txt
NM_053805.1,Snai1	F: AGCAGAGTTGTCTACCGACC	NM_053805.1,68,31,Front_Immunol_2016_Sep_16_7_361.txt
NM_021578.2,Tgfb	F: AGGGCTACCATGCCAACTTC	NM_021578.2,70,30,Front_Immunol_2016_Sep_16_7_361.txt
NM_031132.3,Tgfbr2	F: AGCTCTAACATCCTAGTAAGAAGCG	NM_031132.3,72,37,Front_Immunol_2016_Sep_16_7_361.txt
XM_005028171.2,MGST3	XM_005028171.2	GAGCACGGGCGTATATTCAACTG	AGTGGCTAGGA...,65,7,Front_Microbiol_2016_Mar_31_7_463.txt
XM_005009791.2,THBS1	XM_005009791.2	AGACACTGATTCTGACCGCATAGG	CTTGATTGGC...,66,7,Front_Microbiol_2016_Mar_31_7_463.txt
XM_005009571.2,STX7	XM_005009571.2	GGTATCTGGTGGTGCTCCTGAAG	CTTGTGCTTGA...,67,6,Front_Microbiol_2016_Mar_31_7_463.txt
XM_005029536.2,NDVFA	XM_005029536.2	CTGGAGGTGCCTGAGGTGAG	ACTGCGAGCCGTAG...,68,7,Front_Microbiol_2016_Mar_31_7_463.txt
XM_013108771.1,TPP1	XM_013108771.1	CCTGGCTGCTGCTGCTC	GGCTGTCCTCCTCATCA...,69,6,Front_Microbiol_2016_Mar_31_7_463.txt
XM_013187868.1,SDHB	XM_013187868.1	CGAAACAGGGCAAGGAGCAG	GCAGCAGGCACACA...,70,6,Front_Microbiol_2016_Mar_31_7_463.txt
XM_013107098.1,HSPG	XM_013107098.1	CCACCAACGCCTCCTTCCAG	GACAAATCCACCTT...,74,6,Front_Microbiol_2016_Mar_31_7_463.txt
NM_017169.1,"Peroxiredoxin (Prx) 2: (NM_017169.1):forward, CATGGCCTCCGGCAA;reverse, AAA...",65,25,Front_Neuroanat_2015_Mar_4_9_16.txt
NM_031686.1,"...rse, AAAGGCACCATCCACCACGGCBeta-Synuclein (SNCB): (NM_031686.1):forward, GGGCCTTGTCCCATTCACGGC;revers...",65,117,Front_Neuroanat_2015_Mar_4_9_16.txt
NM_057143.1,"...autosomal recessive, early onset)]7/DJ-1 (DJ-1): (NM_057143.1):forward, ACCGCGCAGGAAAAACACGC;reverse...",65,270,Front_Neuroanat_2015_Mar_4_9_16.txt
NM_017166.1,"...C;reverse, CTGCCAGACGGCTCTGCACStathmin (STMN) 1: (NM_017166.1):forward, TCCGAGCCGCCTGGCTTAGG;reverse...",65,361,Front_Neuroanat_2015_Mar_4_9_16.txt
NM_053019.2,"...′ and 5′-AGGAAGCCAG CAACGCCG-3′ (accession number NM_053019.2, 265 bp) for V1AR, and 5′-AGCATCAGTACC...",35,1040,Front_Neurosci_2013_Aug_30_7_156.txt
NM_017205.2,"...GTACCATCTCCAGG-3′ and 5′-TGGTCTCCATAGTGGCTTCC-3′ (NM_017205.2, 463 bp) for V1BR. The primers used fo...",35,1135,Front_Neurosci_2013_Aug_30_7_156.txt
NM_000257.3,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs3621...,57,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000257.3,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs8632...,58,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000257.3,NM_000257.3(MYH7):c.1816G > A (p.Val606Met) rs1219...,59,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000257.3,NM_000257.3(MYH7):c.2146G > A (p.Gly716Arg) rs1219...,60,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000257.3,NM_000257.3(MYH7):c.2686G > A (p.Asp896Asn) rs6062...,61,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000256.3,NM_000256.3(MYBPC3):c.3641G > A (p.Trp1214Ter) rs7...,64,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000256.3,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs3...,66,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000256.3,NM_000256.3 (MYBPC3):c.3815-1G > A rs397516044	Pat...,67,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000256.3,NM_000256.3 (MYBPC3):c.1357_1358delCC (p.Pro453Cys...,68,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_001001430.2,NM_001001430.2 (TNNT2):c.430C >T (p.Arg144Trp) rs4...,70,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_001001430.2,NM_001001430.2 (TNNT2):c.318C > G (p.Ile106Met) rs...,72,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000363.4,NM_000363.4 (TNNI3):c.422G > A (p.Arg141Gln) rs397...,76,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_000363.4,NM_000363.4 (TNNI3):c.485G > A (p.Arg162Gln) rs397...,77,2,Front_Physiol_2016_Oct_28_7_499.txt
NM_001018005.1,NM_001018005.1 (TPM1):c.644C > T (p.Ser215Leu) rs1...,79,2,Front_Physiol_2016_Oct_28_7_499.txt
XM_006853855.2,...009356 and BK009357. The previous annotated cds # XM_006853855.2 was not modified,50,718,Front_Plant_Sci_2015_Aug_21_6_618.txt
NM_005765.2,"... protocol. Probes for the genes encoding the PRR (NM_005765.2), ATIIR1 (NM_000685.3), ATIIR2 (NM_000...",54,925,Front_Surg_2016_Sep_27_3_51.txt
NM_000685.3,"...the genes encoding the PRR (NM_005765.2), ATIIR1 (NM_000685.3), ATIIR2 (NM_000686.3), ACE (NM_000789...",54,947,Front_Surg_2016_Sep_27_3_51.txt
NM_000686.3,"... PRR (NM_005765.2), ATIIR1 (NM_000685.3), ATIIR2 (NM_000686.3), ACE (NM_000789.2) and the housekeepi...",54,969,Front_Surg_2016_Sep_27_3_51.txt
NM_000789.2,"... ATIIR1 (NM_000685.3), ATIIR2 (NM_000686.3), ACE (NM_000789.2) and the housekeeping gene, and GAPDH ...",54,988,Front_Surg_2016_Sep_27_3_51.txt
NM_002046.3,"...M_000789.2) and the housekeeping gene, and GAPDH (NM_002046.3) were designed and synthesized by Nano...",54,1039,Front_Surg_2016_Sep_27_3_51.txt
XM_005511687.1,"...0072:	Synthesis and  degradation of ketone bodies	XM_005511687.1,XM_005511691.1, XM_005514550.1",141,60,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005511691.1,"... and  degradation of ketone bodies	XM_005511687.1,XM_005511691.1, XM_005514550.1",141,75,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005514550.1,"...n of ketone bodies	XM_005511687.1,XM_005511691.1, XM_005514550.1",141,91,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500333.1,"path:clv00120:	Primary bile acid biosynthesis	XM_005500333.1,XM_005501950.1, XM_005501951.1,  XM...",142,47,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005501950.1,"...20:	Primary bile acid biosynthesis	XM_005500333.1,XM_005501950.1, XM_005501951.1,  XM_005506223.1,XM...",142,62,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005501951.1,"... acid biosynthesis	XM_005500333.1,XM_005501950.1, XM_005501951.1,  XM_005506223.1,XM_005506490.1	XM_...",142,78,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506223.1,"...s	XM_005500333.1,XM_005501950.1, XM_005501951.1,  XM_005506223.1,XM_005506490.1	XM_005506223.1",142,95,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506490.1,"...1,XM_005501950.1, XM_005501951.1,  XM_005506223.1,XM_005506490.1	XM_005506223.1",142,110,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506223.1,"...1, XM_005501951.1,  XM_005506223.1,XM_005506490.1	XM_005506223.1",142,125,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498222.1,"path:clv00561:	Glycerolipid metabolism	XM_005498222.1,XM_005500903.1, XM_005501648.1,  XM...",143,40,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"...:clv00561:	Glycerolipid metabolism	XM_005498222.1,XM_005500903.1, XM_005501648.1,  XM_005506697.1,XM...",143,55,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005501648.1,"...rolipid metabolism	XM_005498222.1,XM_005500903.1, XM_005501648.1,  XM_005506697.1,XM_005509797.1,XM_...",143,71,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506697.1,"...m	XM_005498222.1,XM_005500903.1, XM_005501648.1,  XM_005506697.1,XM_005509797.1,XM_005510541.1	XM_00...",143,88,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005509797.1,"...1,XM_005500903.1, XM_005501648.1,  XM_005506697.1,XM_005509797.1,XM_005510541.1	XM_005499093.1, XM_0...",143,103,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005510541.1,"...1, XM_005501648.1,  XM_005506697.1,XM_005509797.1,XM_005510541.1	XM_005499093.1, XM_005499094.1, XM_...",143,118,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005499093.1,"....1,  XM_005506697.1,XM_005509797.1,XM_005510541.1	XM_005499093.1, XM_005499094.1, XM_005500903.1,",143,133,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005499094.1,"...7.1,XM_005509797.1,XM_005510541.1	XM_005499093.1, XM_005499094.1, XM_005500903.1,",143,149,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"....1,XM_005510541.1	XM_005499093.1, XM_005499094.1, XM_005500903.1,",143,165,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005511837.1,"path:clv00061:	FA biosynthesis	XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_...",144,32,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005505177.1,"path:clv00061:	FA biosynthesis	XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_005515450.1",144,47,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005513915.1,"...1:	FA biosynthesis	XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_005515450.1",144,63,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005515450.1,"...is	XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_005515450.1",144,79,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498018.1,"path:clv00071:	FA degradation	XM_005498018.1, XM_005498222.1, XM_005506697.1,  X...",145,31,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498222.1,"path:clv00071:	FA degradation	XM_005498018.1, XM_005498222.1, XM_005506697.1,  XM_005511837.1	XM...",145,47,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506697.1,"...1:	FA degradation	XM_005498018.1, XM_005498222.1, XM_005506697.1,  XM_005511837.1	XM_005505177.1, XM...",145,63,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005511837.1,"...	XM_005498018.1, XM_005498222.1, XM_005506697.1,  XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_...",145,80,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005505177.1,"..., XM_005498222.1, XM_005506697.1,  XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_005515450.1",145,95,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005513915.1,"..., XM_005506697.1,  XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_005515450.1",145,111,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005515450.1,"...,  XM_005511837.1	XM_005505177.1, XM_005513915.1, XM_005515450.1",145,127,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005511038.1,path:clv01040:	Biosynthesis of unsaturated FAs		XM_005511038.1,146,49,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005509160.1,path:clv00100:	Steroid biosynthesis	XM_005509160.1	XM_005513640.1,147,37,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005513640.1,...ath:clv00100:	Steroid biosynthesis	XM_005509160.1	XM_005513640.1,147,52,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"path:clv00564:	Glycerophospholipid metabolism	XM_005500903.1, XM_005501648.1, XM_005503907.1,  X...",148,47,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005501648.1,"...4:	Glycerophospholipid metabolism	XM_005500903.1, XM_005501648.1, XM_005503907.1,  XM_005510333.1, X...",148,63,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005503907.1,"...olipid metabolism	XM_005500903.1, XM_005501648.1, XM_005503907.1,  XM_005510333.1, XM_005510541.1, X...",148,79,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005510333.1,"...	XM_005500903.1, XM_005501648.1, XM_005503907.1,  XM_005510333.1, XM_005510541.1, XM_005512011.1	XM_...",148,96,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005510541.1,"... XM_005501648.1, XM_005503907.1,  XM_005510333.1, XM_005510541.1, XM_005512011.1	XM_005500903.1, XM_...",148,112,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005512011.1,"... XM_005503907.1,  XM_005510333.1, XM_005510541.1, XM_005512011.1	XM_005500903.1, XM_005512626.1",148,128,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"...,  XM_005510333.1, XM_005510541.1, XM_005512011.1	XM_005500903.1, XM_005512626.1",148,143,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005512626.1,"...1, XM_005510541.1, XM_005512011.1	XM_005500903.1, XM_005512626.1",148,159,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498168.1,"path:clv00140:	Steroid hormone biosynthesis	XM_005498168.1, XM_005500333.1, XM_005504843.1,  X...",149,45,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500333.1,"...140:	Steroid hormone biosynthesis	XM_005498168.1, XM_005500333.1, XM_005504843.1,  XM_005506490.1,XM...",149,61,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005504843.1,"...mone biosynthesis	XM_005498168.1, XM_005500333.1, XM_005504843.1,  XM_005506490.1,XM_005509223.1	XM_...",149,77,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506490.1,"...	XM_005498168.1, XM_005500333.1, XM_005504843.1,  XM_005506490.1,XM_005509223.1	XM_005504843.1",149,94,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005509223.1,"..., XM_005500333.1, XM_005504843.1,  XM_005506490.1,XM_005509223.1	XM_005504843.1",149,109,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005504843.1,"...1, XM_005504843.1,  XM_005506490.1,XM_005509223.1	XM_005504843.1",149,124,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"path:clv00600:	Sphingolipid metabolism	XM_005500903.1, XM_005505197.1, XM_005508143.1,  X...",150,40,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005505197.1,"...clv00600:	Sphingolipid metabolism	XM_005500903.1, XM_005505197.1, XM_005508143.1,  XM_005509734.1	XM...",150,56,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005508143.1,"...olipid metabolism	XM_005500903.1, XM_005505197.1, XM_005508143.1,  XM_005509734.1	XM_005500903.1, XM...",150,72,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005509734.1,"...	XM_005500903.1, XM_005505197.1, XM_005508143.1,  XM_005509734.1	XM_005500903.1, XM_005505196.1, XM_...",150,89,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"..., XM_005505197.1, XM_005508143.1,  XM_005509734.1	XM_005500903.1, XM_005505196.1, XM_005505197.1,  X...",150,104,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005505196.1,"..., XM_005508143.1,  XM_005509734.1	XM_005500903.1, XM_005505196.1, XM_005505197.1,  XM_005508140.1, X...",150,120,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005505197.1,"...,  XM_005509734.1	XM_005500903.1, XM_005505196.1, XM_005505197.1,  XM_005508140.1, XM_005508142.1, X...",150,136,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005508140.1,"...	XM_005500903.1, XM_005505196.1, XM_005505197.1,  XM_005508140.1, XM_005508142.1, XM_005508143.1,  X...",150,153,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005508142.1,"... XM_005505196.1, XM_005505197.1,  XM_005508140.1, XM_005508142.1, XM_005508143.1,  XM_005510696.1",150,169,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005508143.1,"... XM_005505197.1,  XM_005508140.1, XM_005508142.1, XM_005508143.1,  XM_005510696.1",150,185,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005510696.1,"... XM_005508140.1, XM_005508142.1, XM_005508143.1,  XM_005510696.1",150,202,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005503412.1,"path:clv00590:	Arachidonic acid metabolism	XM_005503412.1	XM_005498904.1, XM_005513677.1",151,44,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498904.1,"...00590:	Arachidonic acid metabolism	XM_005503412.1	XM_005498904.1, XM_005513677.1",151,59,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005513677.1,"...ic acid metabolism	XM_005503412.1	XM_005498904.1, XM_005513677.1",151,75,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"path:clv00565:	Ether lipid metabolism	XM_005500903.1, XM_005507270.1, XM_005512011.1	XM_...",152,39,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005507270.1,"...:clv00565:	Ether lipid metabolism	XM_005500903.1, XM_005507270.1, XM_005512011.1	XM_005500903.1, XM_...",152,55,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005512011.1,"... lipid metabolism	XM_005500903.1, XM_005507270.1, XM_005512011.1	XM_005500903.1, XM_005507271.1",152,71,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500903.1,"...sm	XM_005500903.1, XM_005507270.1, XM_005512011.1	XM_005500903.1, XM_005507271.1",152,86,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005507271.1,"...1, XM_005507270.1, XM_005512011.1	XM_005500903.1, XM_005507271.1",152,102,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498269.1,"path:clv03320:	PPAR signaling pathway	XM_005498269.1, XM_005498270.1, XM_005502057.1,  X...",153,39,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005498270.1,"...:clv03320:	PPAR signaling pathway	XM_005498269.1, XM_005498270.1, XM_005502057.1,  XM_005506490.1, X...",153,55,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005502057.1,"...signaling pathway	XM_005498269.1, XM_005498270.1, XM_005502057.1,  XM_005506490.1, XM_005511837.1, X...",153,71,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005506490.1,"...	XM_005498269.1, XM_005498270.1, XM_005502057.1,  XM_005506490.1, XM_005511837.1, XM_005513300.1	XM_...",153,88,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005511837.1,"... XM_005498270.1, XM_005502057.1,  XM_005506490.1, XM_005511837.1, XM_005513300.1	XM_005499093.1, XM_...",153,104,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005513300.1,"... XM_005502057.1,  XM_005506490.1, XM_005511837.1, XM_005513300.1	XM_005499093.1, XM_005499094.1, XM_...",153,120,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005499093.1,"...,  XM_005506490.1, XM_005511837.1, XM_005513300.1	XM_005499093.1, XM_005499094.1, XM_005500050.1,  X...",153,135,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005499094.1,"...1, XM_005511837.1, XM_005513300.1	XM_005499093.1, XM_005499094.1, XM_005500050.1,  XM_005502057.1, X...",153,151,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005500050.1,"...1, XM_005513300.1	XM_005499093.1, XM_005499094.1, XM_005500050.1,  XM_005502057.1, XM_005505177.1, X...",153,167,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005502057.1,"...	XM_005499093.1, XM_005499094.1, XM_005500050.1,  XM_005502057.1, XM_005505177.1, XM_005513915.1,  X...",153,184,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005505177.1,"... XM_005499094.1, XM_005500050.1,  XM_005502057.1, XM_005505177.1, XM_005513915.1,  XM_005515450.1",153,200,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005513915.1,"... XM_005500050.1,  XM_005502057.1, XM_005505177.1, XM_005513915.1,  XM_005515450.1",153,216,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_005515450.1,"... XM_005502057.1, XM_005505177.1, XM_005513915.1,  XM_005515450.1",153,233,G3_(Bethesda)_2016_May_9_6(7)_2081-2090.txt
XM_003357928.1,"ACTB	actin, beta	F:	CGAGCGCTTCCGGTGTCCAG	XM_003357928.1",38,42,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NR_002170.3,RN18S	18S ribosomal RNA	F:	GGGAGGAGGCTGACCGGGTT	NR_002170.3,40,49,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_213801.1,... (glia-activating factor)	F:	TTCCCAGGGGACCCGCAGTC	NM_213801.1,42,82,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_001097413.1,...feron regulatory factor 1	F:	CCTTGTGCACCGTAGGCGGG	NM_001097413.1,44,61,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_001038631.1,...GES	prostaglandin E synthase	F:	TGGTGAGCGGCCAGGTT	NM_001038631.1,46,53,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_001098597.1,OSTN	osteocrin	F:	CCCCTGGACAGACTCTCAGCAGG	NM_001098597.1,48,43,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_001177906.1,...lcium binding protein A9	F:	ACCACATCCTGGAAGACCTG 	NM_001177906.1,50,65,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_213769.1,"...f transcription 1, 91 kDa	F:	AAATGCCGGCGCCAGAACCA	NM_213769.1",52,90,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_001103212.1,STC1	stanniocalcin 1	F:	ACACGCACCAGCGAGCTGAC	NM_001103212.1,54,46,Genes_(Basel)_2015_Dec_21_6(4)_1330-1346.txt
NM_000351.3,...ase chain reaction (PCR) product corresponding to NM_000351.3 (bp 2570–3249) was subcloned into pGEM...,56,60,Genes_Brain_Behav_2011_Apr_10(3)_334-344.txt
NM_020166.3,...e variants were annotated relative to transcripts NM_020166.3 for MCCC1 and NM_022132.4 for MCCC2 us...,43,615,Genet_Med_2015_Aug_6_17(8)_660-667.txt
NM_022132.4,...relative to transcripts NM_020166.3 for MCCC1 and NM_022132.4 for MCCC2 using Variant Effect Predict...,43,641,Genet_Med_2015_Aug_6_17(8)_660-667.txt
NM_020166.3,...riants are reported with reference to transcripts NM_020166.3 for MCCC1 and NM_022132.4 for MCCC2,153,55,Genet_Med_2015_Aug_6_17(8)_660-667.txt
NM_022132.4,...eference to transcripts NM_020166.3 for MCCC1 and NM_022132.4 for MCCC2,153,81,Genet_Med_2015_Aug_6_17(8)_660-667.txt
XM_001603906.1,...and Nasonia vitripennis (GenBank accession number XM_001603906.1). The vasa orthologs of these two s...,31,514,Genet_Mol_Biol_2009_Sep_1_Jul-Sep_32(3)_582-593.txt
NM_001005360.2,"...e compared to the wild-type DNM2 sequence (RefSeq NM_001005360.2), and variants identified were matc...",40,1172,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
NM_204978.1,NM_204978.1	GREM1	CCATGAAGAAGGCTGCAACA	TGCATTGGCCA...,125,1,Genet_Res_Int_2014_Jan_16_2014_318304.txt
NM_205509.2,NM_205509.2	FGFR3	GCTGATTT TGGCCTTGCTAGA	GGCAGCCGA...,126,1,Genet_Res_Int_2014_Jan_16_2014_318304.txt
NR_026365.1,...hinobacterium lividum isolate (NCBI accession no. NR_026365.1),16,342,Genome_Announc_2015_Jun_18_3(3)_e00689-15.txt
NM_000484.1,"...etects three isoforms that match with transcripts NM_000484.1, Y00264 and APP-12 of the APP gene. (c...",119,461,Genome_Biol_2008_Feb_29_9(2)_R46.txt
NM_000859.1,"...ructure of the two transcripts of the HMGCR gene, NM_000859.1 and a variant with a cassette in exon ...",123,145,Genome_Biol_2008_Feb_29_9(2)_R46.txt
NM_012585.1,"...serotonin receptor 1A (5-HT1A, GenBank accession: NM_012585.1; see Albert et al. 1990) and rat serot...",15,198,Histochem_Cell_Biol_2012_Jan_11_137(1)_11-24.txt
NM_012765.3,"...serotonin receptor 2C (5-HT2C, GenBank accession: NM_012765.3; see Julius et al. 1988) mRNA were cho...",15,293,Histochem_Cell_Biol_2012_Jan_11_137(1)_11-24.txt
NM_194277.2,...scribe an uncharacterized FRMD7 missense variant (NM_194277.2:c.875T>C) detected in a Japanese famil...,17,1193,Hum_Genome_Var_2015_Feb_12_2_15002.txt
NM_178559.5,...ltiple variant sets and even the same transcript (NM_178559.5) is associated with multiple variant s...,42,753,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_001163941.1,NA20805	NM_001163941.1	7619,46,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_001163942.1,NA20805	NM_001163942.1	3062,47,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_001163993.2,NA20805	NM_001163993.2	3062,48,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_178559.5,NA20805	NM_178559.5	7619,49,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_178559.5,NA20806	NM_178559.5	2807,50,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_001163993.2,NA20806	NM_001163993.2	3062,51,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_001163942.1,NA20806	NM_001163942.1	3062,52,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_001163941.1,NA20806	NM_001163941.1	2807,53,9,Hum_Genomics_2015_Jul_30_9(1)_18.txt
NM_058004.3,...ant in PI4KA was a c.2386C>T mutation in exon 20 (NM_058004.3) that is predicted to result in premat...,46,1478,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
NM_001037220.4,...40–2413 of rat AP5Z1 transcript (accession number NM_001037220.4),96,543,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
NM_000071.2,"...nitiation codon in the reference GenBank sequence NM_000071.2, according to the Journal guidelines (...",44,317,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
NM_000071.2,"...nitiation codon in the reference GenBank sequence NM_000071.2, according to the Journal guidelines (...",50,155,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
NM_041805.3,...s the annotated initiation sites of the EPM2AIP1 [NM_041805.3] and MLH1 [NM_000249.3] genes. This 39...,41,207,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
NM_000249.3,...ion sites of the EPM2AIP1 [NM_041805.3] and MLH1 [NM_000249.3] genes. This 393 bp product was locate...,41,230,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
NM_000249.3,...ss the MLH1 promoter (c.-960 to c.107 relative to NM_000249.3) in constitutional DNA from both proba...,48,162,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
NM_000249.3,...amond). Black arrows indicate the annotated MLH1 [NM_000249.3] or EPM2AIP1 [NM_014805.3] transcripti...,67,1370,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
NM_014805.3,"...ate the annotated MLH1 [NM_000249.3] or EPM2AIP1 [NM_014805.3] transcription initiation sites, where...",67,1396,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
NM_008361.3,IL1β	NM_008361.3	mIL1β-F1	CTATACCTGTCCTGTCTA	mIL1β-R1	G...,93,6,Immun_Ageing_2015_Nov_24_12_22.txt
NM_031168.1,IL6	NM_031168.1	mIL6-F1	CTGAAACTTCCAGAGATA	mIL6-R1	TTC...,94,5,Immun_Ageing_2015_Nov_24_12_22.txt
NM_013693.2,TNFα	NM_013693.2	mTNFα-F1	TTCTGTCTACTGAACTTC	mTNFα-R1	C...,95,6,Immun_Ageing_2015_Nov_24_12_22.txt
NM_010548.2,IL10	NM_010548.2	mIL10-F1	CTATGCTGCCTGCTCTTA	mIL10-R1	G...,96,6,Immun_Ageing_2015_Nov_24_12_22.txt
NM_009367.3,TGFβ	NM_009367.3	mTGFβ-F1	AGAGAAGAACTGCTGTGT	mTGFβ-R1	G...,97,6,Immun_Ageing_2015_Nov_24_12_22.txt
NM_008084.2,GAPDH	NM_008084.2	mGAPDH-F1	GTGAAGGTCGGTGTGAAC	mGAPDH-R1...,98,7,Immun_Ageing_2015_Nov_24_12_22.txt
NM_018009.4,"...script for TAPBPR α has previously been reported (NM_018009.4). β, γ, δ, ε, ζ, η mRNA products have ...",45,799,Immunology_2014_Jun_24_142(2)_289-299.txt
NM_001128636.2,...gion of a conservative gene ELFN1 (NCBI Ref. Seq. NM_001128636.2) in primate lineage. Homologous seq...,75,99,Infect_Agent_Cancer_2016_Jul_19_11_34.txt
XM_004523388.1,"...d from NCBI website with the accession numbers of XM_004523388.1 and XM_004523387.1, respectively. T...",45,256,Insect_Biochem_Mol_Biol_2014_May_48(100)_51-62.txt
XM_004523387.1,"... with the accession numbers of XM_004523388.1 and XM_004523387.1, respectively. The genomic sequence...",45,275,Insect_Biochem_Mol_Biol_2014_May_48(100)_51-62.txt
XM_004523388.1,CcapObp83a-1	XM_004523388.1	123	207	76	5515	257	75	18	6271,136,14,Insect_Biochem_Mol_Biol_2014_May_48(100)_51-62.txt
XM_004523387.1,CcapObp83a-2	XM_004523387.1	96	63	76	82	257	79	18	671,137,14,Insect_Biochem_Mol_Biol_2014_May_48(100)_51-62.txt
NM_079517.2,DmelObp83a (OS–F)	NM_079517.2	114	79	76	427	257	54	18	1025,138,19,Insect_Biochem_Mol_Biol_2014_May_48(100)_51-62.txt
NM_079518.2,DmelObp83b (OS-E)	NM_079518.2	72	62	76	51	278	Not apply	Not apply	53...,139,19,Insect_Biochem_Mol_Biol_2014_May_48(100)_51-62.txt
XM_393334.4,"...ibolium castaneum (XM_001813544), Apis mellifera (XM_393334.4), and Drosophila melanogaster (NM_1651...",27,515,Insects_2012_Nov_16_3(4)_1190-1199.txt
NM_165189.2,"...ifera (XM_393334.4), and Drosophila melanogaster (NM_165189.2), and they were used to expand the ter...",27,558,Insects_2012_Nov_16_3(4)_1190-1199.txt
NM_006665.3,"Three RNAi sequences that target HPSE (NM_006665.3, Figure 1A) were designed and screened...",26,40,Int_J_Biol_Sci_2013_Jun_12_9(6)_564-577.txt
NM_002467.4,...cted by cloning a 1365-bp fragment of C-myc cDNA (NM_002467.4) into the BamHI and XhoI sites of pcDN...,48,623,Int_J_Biol_Sci_2015_Jan_1_11(1)_1-10.txt
NM_030845.1,Cxcl1	TCGCCAATGAGCTGCGCTGT	GGGACACCCTTTAGCATCTT	NM_030845.1,112,49,Int_J_Cardiol_2013_Mar_10_163(3)_326-334.txt
NM_053565.1,Socs3	TGGTCACCCACAGCAAGTTT	ACCAGCTTGAGTACACAGTC	NM_053565.1,115,49,Int_J_Cardiol_2013_Mar_10_163(3)_326-334.txt
NM_001106897.1,IL-17A	AGGCCCTCAGACTACCTCA	TCTCAGGCTCCCTCTTCAG	NM_001106897.1,116,48,Int_J_Cardiol_2013_Mar_10_163(3)_326-334.txt
NM_001107883.2,IL-17RA	GGGTGTATGGCCTCATCAC	ACAGGCAGTGATCAGGAACT	NM_001107883.2,117,50,Int_J_Cardiol_2013_Mar_10_163(3)_326-334.txt
NM_001015011.1,IL-17 F	GGAGGATAACAGTGTGAGAG	ATTTCTTGCTGGATGGGGAC	NM_001015011.1,118,51,Int_J_Cardiol_2013_Mar_10_163(3)_326-334.txt
NM_031530.1,MCP-1	TGCAGTTAATGCCCCACTCA	TCTCACTTGGTTCTGGTCCA	NM_031530.1,119,49,Int_J_Cardiol_2013_Mar_10_163(3)_326-334.txt
NM_000547.5,"...cript, TPO1, is 3152 bp (GenBank accession number NM_000547.5) which encodes 933 amino acids. TPO is...",22,180,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
NM_010902.3,"...anghai, China) as follows: Nrf2 accession number (NM_010902.3): forward (ttggcagagacattcccatttg) and...",33,818,Int_J_Environ_Res_Public_Health_2015_Oct_12_12(10)_12628-12642.txt
NM_010362.2,...gggatgagctagtgctgatctgg); Gsto1 accession number (NM_010362.2): forward (cttcatggcgtagttgaatgatgtc) ...,33,1036,Int_J_Environ_Res_Public_Health_2015_Oct_12_12(10)_12628-12642.txt
NM_001124357.1,TNF-α	CGCTGACACAGTGCAGTGGA	TCCCCGATGGAGTCCGAATA	NM_001124357.1,87,49,Int_J_Genomics_2013_Aug_29_2013_619714.txt
NM_001042660.1,...or the mouse Smad7 gene (NCBI reference sequence: NM_001042660.1) were acquired by oligonucleotide s...,44,110,Int_J_Mol_Med_2015_Dec_9_36(6)_1497-1506.txt
XM_002278960.1,"...nthus roseus, AY837788.2), VvPOD (Vitis vinifera, XM_002278960.1), GhPOD (Gossypium hirsutum, AY3115...",116,240,Int_J_Mol_Sci_2013_Feb_4_14(2)_3158-3177.txt
XM_003523221.1,"...sypium hirsutum, AY311597.1), GmPOD (Glycine max, XM_003523221.1), MtPOD (Medicago truncatula, XM_00...",116,317,Int_J_Mol_Sci_2013_Feb_4_14(2)_3158-3177.txt
XM_003616700.1,"...max, XM_003523221.1), MtPOD (Medicago truncatula, XM_003616700.1) and RcPOD (Rubia cordifolia, HM807...",116,362,Int_J_Mol_Sci_2013_Feb_4_14(2)_3158-3177.txt
NM_131393.1,Non-mammals	Zebrafish	NM_131393.1	NM_131395.1	NM_001161484.1,61,23,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_131395.1,Non-mammals	Zebrafish	NM_131393.1	NM_131395.1	NM_001161484.1,61,35,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001161484.1,Non-mammals	Zebrafish	NM_131393.1	NM_131395.1	NM_001161484.1,61,47,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_205362.1,Chicken	NM_205362.1	XM_417201.2	NM_205361.1,64,10,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_417201.2,Chicken	NM_205362.1	XM_417201.2	NM_205361.1,64,22,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_205361.1,Chicken	NM_205362.1	XM_417201.2	NM_205361.1,64,34,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001048257.1,Zebra finch	NM_001048257.1	NM_001048258.1	XM_002193412.1,65,14,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001048258.1,Zebra finch	NM_001048257.1	NM_001048258.1	XM_002193412.1,65,29,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_002193412.1,Zebra finch	NM_001048257.1	NM_001048258.1	XM_002193412.1,65,44,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_001917051.1,Mammals	Horse	XP_001490221.1	XM_001917051.1,68,30,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_004040725.1,Gorilla gorilla	XM_004040725.1	XM_004051965.1,69,18,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_004051965.1,Gorilla gorilla	XM_004040725.1	XM_004051965.1,69,33,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_003984615.1,Cat	XM_003984615.1	XM_003992620.1,70,6,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_003992620.1,Cat	XM_003984615.1	XM_003992620.1,70,21,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_005958.3,Human	NM_005958.3	NM_005959.3		NM_004224.3,71,8,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_005959.3,Human	NM_005958.3	NM_005959.3		NM_004224.3,71,20,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_004224.3,Human	NM_005958.3	NM_005959.3		NM_004224.3,71,33,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_526799.2,Chimpanzee	XM_526799.2	XM_522146.4,72,13,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_522146.4,Chimpanzee	XM_526799.2	XM_522146.4,72,25,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_053676.2,Rat	NM_053676.2	NM_001100641.1		NM_001191915.1,73,6,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001100641.1,Rat	NM_053676.2	NM_001100641.1		NM_001191915.1,73,18,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001191915.1,Rat	NM_053676.2	NM_001100641.1		NM_001191915.1,73,34,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_540019.3,Dog	XM_540019.3	XM_844629.2,74,6,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_844629.2,Dog	XM_540019.3	XM_844629.2,74,18,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_008639.2,Mouse	NM_008639.2	NM_145712.2		NM_010340.1,75,8,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_145712.2,Mouse	NM_008639.2	NM_145712.2		NM_010340.1,75,20,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_010340.1,Mouse	NM_008639.2	NM_145712.2		NM_010340.1,75,33,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
XM_002698656.1,Cow	XM_002698656.1	NM_001206907.1,76,6,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001206907.1,Cow	XM_002698656.1	NM_001206907.1,76,21,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001130938.1,Sheep	NP_001009725.1	NM_001130938.1		NM_001009726.1,77,23,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001009726.1,Sheep	NP_001009725.1	NM_001130938.1		NM_001009726.1,77,39,Int_J_Mol_Sci_2013_May_27_14(6)_11208-11223.txt
NM_001009784.1,ACTB	Beta-actin	Cytoskeletal structural protein	NM_001009784.1	Actin cytoplasmic 1; beta-actin,79,49,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
XM_004012836.1,... protein L19	Found in the large ribosomal subunit	XM_004012836.1,80,66,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
NM_001009284.2,... major histocompatibility complex (MHC) molecules	NM_001009284.2,81,95,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
NM_001190390.1,...e dehydrogenase	Enzyme in carbohydrate metabolism	NM_001190390.1	GAPD; G3PDH,82,82,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
NM_001267887.1,"protein, zeta polypeptide	Signal transduction	NM_001267887.1	14-3-3 protein zeta/delta; tyrosine...",86,47,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
XM_004017097.1,"...omplex, subunit A	Mitochondrial respiratory chain	XM_004017097.1",87,81,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
NM_001142516.1,"...cerate to ADP, forming ATP and 3-phosphoglycerate	NM_001142516.1",88,160,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
NM_001093780.1,...e dehydrogenase	Enzyme in carbohydrate metabolism	NM_001093780.1,89,74,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
XM_004022693.1,... 1	Phosphoribosyl-transferase (PRT)-type I domain	XM_004022693.1	HPRT1,90,95,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
XM_004003001.1,"...in containing proteins, like transferrin receptor	XM_004003001.1	p90; CD71",91,101,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
XM_004004772.1,...ycophorin C	Integral RBC membrane binding protein	XM_004004772.1	BOS_1916; CD236; CD236R,92,58,Int_J_Mol_Sci_2013_May_30_14(6)_11484-11495.txt
NM_182489.1,Homo sapiens	66.5%	NM_182489.1,36,20,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_575429.2,Rattus norvegicus	72.1%	XM_575429.2,37,25,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
NM_009292.1,Mus musculus	78.4%	NM_009292.1,38,20,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_001253649.1,Bos taurus	57.8%	XM_001253649.1,39,18,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_847727.2,Canis lupus familiaris	66.4%	XM_847727.2,40,30,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_416179.3,Gallus gallus	45.4%	XM_416179.3,41,21,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_001914766.1,Equus caballus	75.0%	XM_001914766.1,42,22,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_002818472.1,Pongo abelii	66.8%	XM_002818472.1,43,20,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
XM_001144872.2,Pan troglodytes	66.6%	XM_001144872.2,44,23,Int_J_Mol_Sci_2014_Jul_15_15(7)_12480-12494.txt
NM_005180.5,"ShRNA constructs Bmi1/pLKO.1 (TRCN0000020155, NM_005180.5-693s1c1) used to silence Bmi1 expressi...",66,47,Int_J_Mol_Sci_2014_Nov_3_15(11)_20004-20021.txt
NM_001204878.1,"...e genes were: BCL2-associated athanogene 4 (BAG4, NM_001204878.1) found in one clone; Pongo abelii B...",21,809,Int_J_Mol_Sci_2015_Apr_2_16(4)_7462-7477.txt
NM_144695.3,"...elii BRO1 domain and CAAX motif containing (Brox, NM_144695.3) was found in three clones; radixin (R...",21,903,Int_J_Mol_Sci_2015_Apr_2_16(4)_7462-7477.txt
NM_001260492.1,"...44695.3) was found in three clones; radixin (RDX, NM_001260492.1) in one clone; lysocardiolipin acyl...",21,957,Int_J_Mol_Sci_2015_Apr_2_16(4)_7462-7477.txt
NM_001002257.1,"...ne clone; lysocardiolipin acyltransferase (LYCAT, NM_001002257.1) in two clones; protein phosphatase...",21,1027,Int_J_Mol_Sci_2015_Apr_2_16(4)_7462-7477.txt
NM_002709.2,"...atase 1, catalytic subunit, beta isozyme (PPP1CB, NM_002709.2) in one; and chromosome 6 open reading...",21,1122,Int_J_Mol_Sci_2015_Apr_2_16(4)_7462-7477.txt
XM_005249433.1,"... and chromosome 6 open reading frame 62 (C6ORF62, XM_005249433.1) in one clone",21,1192,Int_J_Mol_Sci_2015_Apr_2_16(4)_7462-7477.txt
NM_007392.3,β-actin	Fwd	TTG CTG ACA GGA TGC AGA AG	NM_007392.3	58.2	147	1039–1058,99,40,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_016850.3,Irf7	Fwd	GAT CTT CAA GGC CTG GGC TGT GG	NM_016850.3	57.1	220	611–633,101,41,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_025378.2,Ifitm3	Fwd	GAT CGG CTT CTG TCA GAA CTA	NM_025378.2	57.2	154	209–229,103,40,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_133211.4,Tlr7	Fwd	TGT TAC TAT TCC ATA CCT GGC CAC	NM_133211.4	60.1	179	2640–2663,105,42,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_031178.2,Tlr9	Fwd	CAA CAT GGT TCT CCG TCG AA	NM_031178.2	58.2	243	103–122,107,37,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_011611.2,Cd40	Fwd	TTG TTG ACA GCG GTC CAT CT	NM_011611.2	59.6	154	112–131,109,37,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_001110193.2,Ship1	Fwd	CCA GGG CAA GAT GAG GGA GA	NM_001110193.2	60.98	195	2766–2785,111,38,Int_J_Mol_Sci_2016_Aug_6_17(8)_1282.txt
NM_008061.3,G6Pase	NM_008061.3	F: GAACAACTAAAGCCTCTGAAAC	350	50,210,8,Int_J_Mol_Sci_2016_Jun_3_17(6)_872.txt
NM_023114.3,apo C-III	NM_023114.3	F: CAGTTTTATCCCTAGAAGCA	349	47,216,11,Int_J_Mol_Sci_2016_Jun_3_17(6)_872.txt
NM_008288.2,11β-HSD1	NM_008288.2	F: AAGCAGAGCAATGGCAGCAT	300	50,226,10,Int_J_Mol_Sci_2016_Jun_3_17(6)_872.txt
NM_007472.2,Reverse: CCCACCCAGAAAATCCAGTG	NM_007472.2,110,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_009699.3,Reverse : AGAAGACCCAGTGATCATCAAAC	NM_009699.3,112,35,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_016689.2,Reverse: GAAGACACCAGCGATGGAAC	NM_016689.2,114,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_009700.2,Reverse: GCTGCGCGGCTTTGCTGAAG	NM_009700.2,116,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_009701.4,Reverse: AGAAGTAGAGGATTGCAGCC	NM_009701.4,118,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_175087.4,Reverse: GCCAGTTGATGTGCTGTTG	NM_175087.4,120,30,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_007473.4,Reverse: GCCACGGAACCAAGGCCAAACAC	NM_007473.4,122,34,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_007474.2,Reverse: CGCCAGCAGTTCTTCTTCAC	NM_007474.2,124,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_022026.3,Reverse: GCTGTTGGGATCAAACTGGA	NM_022026.3,126,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_175105.3,Reverse: ACTGTCCTGGGACTTAGTTC	NM_175105.3,128,31,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_177587.2,Reverse: GAGGACAGCCAGGATCATC	NM_177587.2,130,30,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_023144.2,Reverse : CCGGAGCTGGACGGTTGAATGC	NM_023144.2,132,34,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_007393.3,Reverse : GACCCCGTCTCCGGAGTCCATC	NM_007393.3,134,34,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
NM_011740.3,Reverse : GCCGGTTAATTTTCCCCTCC	NM_011740.,136,32,Int_J_Mol_Sci_2016_Oct_18_17(10)_1742.txt
XM_545208.4,"...tol-4,5-bisphosphate 3-kinase catalytic subunit α	XM_545208.4",274,69,Int_J_Mol_Sci_2016_Sep_21_17(9)_1589.txt
NM_214192.1,...talloproteinase-2	MMP2	F: CGGACAAGAGTTGGCTGTGCAAT	NM_214192.1	506 bp,214,60,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
NM_001001771.1,Fibrilin	FBN1	F: TGGGATTTACCGTGCTTTAGCGT	NM_001001771.1	381 bp,218,42,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
XM_003125303.1,Emilin	EMILIN1	F: ACAAGACAGTGACGGAGATGGAGT	XM_003125303.1	399 bp,220,44,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
NM_001243655.1,...ype I collagen	COL1A1	F: GAACCAAAGGGCCCAAAGGTGAAA	NM_001243655.1	301 bp,222,60,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
XM_003133535.1,...e III collagen	COL3A1	F: AGCCAGAACGATGCCAAATATGCG	XM_003133535.1	654 bp,224,62,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
XM_003131091.4,...pe IV collagen	COL4A1	F: ACAGTGCCACTCTATAGCGGGTTT	XM_003131091.4	301 bp,226,61,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
NM_214230.1,Tenascin	TNC	F: TTCAGTCGGAAACAGCCCTTCTCA	NM_214230.1	347 bp,228,42,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
XM_003134653.1,Caldesmon 1	CALD1	F: AGCTTCTTCGGTGGAAAGAGGGA	XM_003134653.1	854 bp,230,46,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
NM_214084.1,...growth factor A	VEGFA	F: TTCTGCTCTCTTGGGTGCATTGGA	NM_214084.1	296 bp,232,72,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
NM_001206359.1,...de 3-phosphate	GAPDH	F: AAGGTCGGAAGTCAACGGATTTGGT	NM_001206359.1	450 bp,234,63,Int_J_Nanomedicine_2016_Oct_12_11_5041-5055.txt
NM_003181.2,"...hyury (mouse) homolog (T; Gene bank accession no. NM_003181.2), CD24 antigen (CD24; Gene bank access...",48,681,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_013230.2,"...1.2), CD24 antigen (CD24; Gene bank accession no. NM_013230.2), insulin-like growth factor binding p...",48,739,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_000597.2,"...inding protein 2 (IGFBP2; Gene bank accession no. NM_000597.2), retinoic acid receptor responder 2 (...",48,831,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_002889.3,"...tor responder 2 (RARRES2; Gene bank accession no. NM_002889.3), esophageal cancer-related gene 4 pro...",48,914,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_032411.2,"...ed gene 4 protein (ECRG4; Gene bank accession no. NM_032411.2), keratin 18 (KRT18; Gene bank accessi...",48,1001,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_000224.2,"...11.2), keratin 18 (KRT18; Gene bank accession no. NM_000224.2), podoplanin/T1A-2 lung type-I cell me...",48,1058,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_006474.4,"... glycoprotein (PDPN/T1A2; Gene bank accession no. NM_006474.4), and osteopontin (SSP1; Gene bank acc...",48,1175,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_001040058.1,"...), and osteopontin (SSP1; Gene bank accession no. NM_001040058.1). For all primer sets, hot start PC...",48,1236,Int_J_Oncol_2014_Jan_21_44(4)_1041-1055.txt
NM_008639.2,R: ACGCTGAGCTGACAGACTGGGT	NM_008639.2,94,27,Iran_J_Basic_Med_Sci_2013_Aug_16(8)_906-909.txt
NM_016993.1,Bcl-2	NM_016993.1	F: F: CGGGAGAACAGGGTATGA,44,7,Iran_J_Basic_Med_Sci_2016_Apr_19(4)_381-387.txt
NM_017008.4,GAPDH	NM_017008.4	F: TGCCGCCTGGAGAAACCTGC,46,7,Iran_J_Basic_Med_Sci_2016_Apr_19(4)_381-387.txt
